SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                   FORM 10-K\A
                                (AMENDMENT NO. 2)

              ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                  FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 1997
                          COMMISSION FILE NUMBER 1-8137

                          AMERICAN PACIFIC CORPORATION
             (Exact name of registrant as specified in its charter)

                  DELAWARE                                      59-6490478
          (State or other jurisdiction                        (IRS Employer
               of incorporation)                             Identification No.)

          3770 HOWARD HUGHES PARKWAY, SUITE 300,
          LAS VEGAS, NEVADA                                        89109
          (Address of principal executive office)                  (Zip Code)

                                 (702) 735-2200
              (Registrant's telephone number, including area code)

        Securities registered pursuant to Section 12(b) of the Act: None

          Securities registered pursuant to Section 12(g) of the Act:
                          Common Stock ($.10 par value)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.

                           YES      X              NO ______

Indicate by check mark if disclosure of delinquent  filers  pursuant to Item 405
of Regulation  S-K is not contained  herein,  and will not be contained,  to the
best of registrant's  knowledge,  in definitive proxy or information  statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. ( )

The  aggregate  market value of the voting stock held by  non-affiliates  of the
registrant as of December 1, 1997, was approximately $57,600,000. Solely for the
purposes of this  calculation,  shares  held by  directors  and  officers of the
Registrant  have  been  excluded.   Such  exclusion   should  not  be  deemed  a
determination by the Registrant that such  individuals are, in fact,  affiliates
of the Registrant.

The number of shares of Common Stock, $.10 par value, outstanding as of December
1, 1997 was 8,137,537.


                                        1
<PAGE>
                       DOCUMENTS INCORPORATED BY REFERENCE

         Definitive  Proxy  Statement for 1998 Annual Meeting of Stockholders to
be filed not later than January 28, 1998 (Part III hereof).

         S-14 Registration Statement (2-70830); Annual Reports on Forms 10-K for
the  years  ended  September  30,  1995 and  1993;  S-2  Registration  Statement
(33-36664);  Quarterly Report on Form 10-Q for the fiscal quarter ended December
31, 1990; S-8 Registration  Statement  (33-52898);  S-3  Registration  Statement
(33-52196)  and  Current  Report  on Form 8-K  dated  February  28,  1992;  (all
incorporated by reference in Part IV hereof).




















                                        2


<PAGE>
                                     PART 1

ITEM 1. BUSINESS

         American  Pacific   Corporation  (the  "Company")  is  engaged  in  the
production  of a  specialty  chemical,  ammonium  perchlorate  ("AP"),  for  the
aerospace and national  defense  industries.  The Company is one of two domestic
manufacturers  of AP, which is used primarily as an oxidizing agent in composite
solid  propellants  for rockets,  booster  motors and  missiles.  The  Company's
customers  for  AP  are  primarily  contractors  in  programs  of  the  National
Aeronautics  and Space  Administration  ("NASA") and the  Department  of Defense
("DOD"),  and companies providing  commercial  satellite launch services.  These
NASA and DOD contractors are engaged in space  exploration  projects such as the
Space Shuttle Program and in the production of defense systems.  Other customers
for  the  Company's  AP  include  aerospace  and  defense  agencies  of  foreign
countries.

         On  October  17,  1997,  the  Company  entered  into an Asset  Purchase
Agreement (the "Agreement") with Kerr-McGee Chemical Corporation ("Kerr-McGee"),
the only other domestic  manufacturer  of AP,  providing for the purchase by the
Company  of  certain  process  data,  technical  information,  customers  lists,
marketing  contacts and related expertise of Kerr-McGee related to AP production
and Kerr-McGee's  business  relating to such assets and the manufacture and sale
of AP. Under the Agreement, Kerr-McGee agreed to cease production and sale of AP
except  in  the  limited   circumstances  set  forth  in  the  Agreement.   Upon
consummation  of the  transaction,  the Company  will  become the sole  domestic
manufacturer of AP. See "Ammonium Perchlorate - Agreement with Kerr-McGee."

         The  Company is a party to  agreements  with  Dynamit  Nobel  A.G.,  of
Germany  ("Dynamit  Nobel") relating to the production and sale of sodium azide,
the principal  component of a gas generant used in  automotive  airbag  systems.
Dynamit  Nobel  licensed to the  Company,  on an  exclusive  basis for the North
American market,  its technology and know-how in the production of sodium azide,
and has provided technical support for the design,  construction and start-up of
the  Company's  sodium azide  facility.  Funding for the facility was  partially
provided by means of the sale of  $40,000,000  principal  amount of  noncallable
subordinated  secured notes (the "Azide Notes") to a major state public employee
retirement  fund  and a  leading  investment  management  company.  The  Company
commenced  commercial sales of sodium azide in fiscal 1994. In January 1996, the
Company filed an antidumping petition with the United States International Trade
Commission ("ITC") and the United States Department of Commerce  ("Commerce") in
response to the  unlawful  pricing  practices  of Japanese  producers  of sodium
azide.  In the  fourth  quarter  of  fiscal  1997,  the  Company  recognized  an
impairment  charge  of  $52,605,000  relating  to the fixed  assets  used in the
production  of sodium  azide.  See "Sodium  Azide - Market" and "Sodium  Azide -
Competition."

         In  February  1992,  the  Company  acquired  (by  exercise of an option
previously  granted to it) the worldwide rights to Halotron,  a fire suppression
system that includes chemical compounds and application  technology  intended to
replace  halons,  which have been found to be ozone  layer-depleting  chemicals.
Halotron has applications as a fire suppression  agent for military,  commercial
and industrial uses.

         The Company is also  engaged in the  development  of real estate and in
the production of environmental protection and waste water treatment equipment.

         See Note 12 to the Notes to  Consolidated  Financial  Statements of the
Company for information concerning revenues,  operating profits and identifiable
assets of the Company's  industry  segments and for financial  information about
domestic  operations  and  export  sales.  The  Company's  perchlorate  chemical
operations accounted for


                                        3


<PAGE>
approximately  52%, 51% and 75% of revenues during the years ended September 30,
1997,  1996 and 1995,  respectively.  The term "Company"  used herein  includes,
where the context requires,  one or more of the direct and indirect subsidiaries
or divisions of American Pacific Corporation.

SPECIALTY CHEMICALS

STRATEGY

         The Company's  strategy is to become the premier  producer of AP and to
apply the technology and expertise  gained over 30 years in the production of AP
to other activities,  such as sodium azide and Halotron,  perchlorate  chemicals
other than AP, and additional specialty chemical business opportunities,  and to
its environmental protection equipment business. The Company's strategy has been
to use proven  technologies  and  target  growing  markets  to produce  and sell
specialty  chemicals for which there is perceived  demand.  Where feasible,  the
Company  may  endeavor  to gain  access  to such  technologies  and  markets  by
cooperative  arrangements  with others to which it can  contribute its operating
and management expertise. The Company regularly evaluates business opportunities
that are presented to it.

AMMONIUM PERCHLORATE

MARKET

         AP is the sole oxidizing  agent for solid fuel rockets,  booster motors
and missiles used in space exploration,  commercial satellite transportation and
national defense programs.  A significant  number of existing and planned launch
vehicles providing access to space for communications, observation, intelligence
and scientific  exploration are propelled by solid fuel rockets and thus depend,
in part,  upon AP.  Many of the rockets and  missiles  used in national  defense
programs are also powered by solid fuel.

         The Company has supplied AP for use in space  exploration  programs for
over 30 years,  beginning with the Titan program in the early 1960s.  Today, its
principal space exploration customer is the Space Shuttle Program, for which the
Company  supplies  approximately  one-half  to  substantially  all of Program AP
requirements.  The Company's AP is also used in  expendable  rockets that launch
satellites  for  communications,   navigation,   intelligence  gathering,  space
exploration,  weather forecasting and environmental monitoring. The Company is a
qualified  supplier of AP to a number of defense  programs,  including  the Navy
Standard Missile, Patriot, and Multiple Launch Rocket System programs.

         Demand  for AP has  declined  steadily  over the past  five  years  but
appears to have  leveled  off  recently on a  worldwide  basis at  approximately
20,000,000  pounds  annually.  Supply capacity is substantially in excess of the
estimated  demand  levels.  In an attempt to  rationalize  the AP industry,  the
Company entered into the Agreement with Kerr-McGee.  See "Ammonium Perchlorate -
Agreement with Kerr-McGee."


CUSTOMERS

         Prospective  purchasers of AP consist  principally  of  contractors  in
programs of the DOD and NASA. As a practical matter,  the specialized  nature of
these  contractors'  activities  restricts entry by others into competition with
them. As a result,  there are  relatively  few  potential  customers for AP, and
individual


                                        4


<PAGE>
customers for AP typically account for a significant  portion of the revenues of
AP  manufacturers.   Prospective  customers  also  include  companies  providing
commercial  satellite  launch  services and agencies of foreign  governments and
their contractors.  Historically sales to foreign agencies and their contractors
have not  accounted  for  significant  percentages  of AP sales.  See  "Ammonium
Perchlorate - Competition."

         Thiokol Corporation  ("Thiokol")  accounted for 35%, 47% and 71% of the
Company's  revenues  during the fiscal years ended  September 30, 1997, 1996 and
1995,  respectively.   Alliant  Techsystems,   Inc.  ("Alliant")  accounted  for
approximately  10% of the  Company's  revenues  during  the  fiscal  year  ended
September 30, 1997.

BACKLOG

         In September 1997, the Company received a purchase order for deliveries
of AP to Thiokol during the fiscal year ending  September 30, 1998. The purchase
order amounts to  approximately  $16.1  million.  In October  1995,  the Company
received a purchase  order from  another  customer  for the  delivery of AP from
October  1996  through  1999  having a value in the range of $8  million  to $10
million.  Approximately  $4.5 million of this  purchase  order was  delivered in
fiscal 1997. This purchase order includes  options that could increase the order
during the  1998-1999  period,  and that could extend the purchase  order to the
year 2000. As a result of the above purchase  orders,  the Company has a backlog
of approximately $18.3 million for deliveries of AP in fiscal 1998.

MANUFACTURING CAPACITY AND PROCESS

         Production  of AP  at  the  Company's  current  manufacturing  facility
commenced in July 1989. This facility,  as currently  configured,  is capable of
producing  30,000,000  pounds  of  AP  annually.  It  is  expandable  to  enable
production of up to 40,000,000 pounds annually.  AP produced at the facility and
propellants  incorporating  such AP have  qualified  for use in all NASA and DOD
programs for which testing has been conducted.  Since the qualification  process
was  completed,  AP produced  at the  facility  has been used in numerous  Space
Shuttle  launches.  AP produced by the Company is also used in programs  such as
the Navy  Standard  Missile and  Multiple  Launch  Rocket  System  programs  and
Alliant's Delta program.

         The AP  facility  is  designed  to site  particular  components  of the
manufacturing  process in discrete areas of the facility. It incorporates modern
equipment and materials  handling systems designed,  constructed and operated in
accordance  with the  operating  and safety  requirements  of the  Company's  AP
customers,  insurance carriers and governmental authorities.  Equipment required
in the  manufacturing  process includes storage tanks for use at various stages,
electrolytic cells,  glass-lined reactor vessels,  crystallizer vessels,  dryers
and blenders.

         AP is  manufactured  by  electrochemical  processes using the Company's
proprietary  technology.  The principal raw materials used in the manufacture of
AP (other than electrical  energy) are salt,  ammonia and hydrochloric acid. All
of the raw  materials  used in the AP  manufacturing  process are  available  in
commercial  quantities  and the  Company  has  had no  difficulty  in  obtaining
necessary raw materials.  The Company is a party to an agreement with Utah Power
&  Light  Company  for  its  electrical  requirements  at the  AP  manufacturing
facility.  Prices  paid by the Company for raw  materials  have been  relatively
stable,  with  no  discernible  long-term  price  fluctuations.   The  Company's
agreement  with  Utah  Power and Light  provides  for the  supply of power for a
minimum  ten-year  period,  which began in 1988,  and  obligates  the Company to
purchase  minimum  amounts of power,  while  assuring  the  Company  competitive
pricing for its electricity needs for the duration of the agreement. The Company
is in the process of negotiations for its


                                        5


<PAGE>
expected power  requirements  beyond 1998. The Company's AP production  requires
substantial amounts of electric power.

         The AP manufacturing  process is basically  non-patentable.  Certain of
its aspects are  proprietary  to the Company and  knowledge of these  aspects is
confined to a small  number of  personnel  upon whose  expertise  the Company is
dependent.  The  Company  has  entered  into  appropriate  agreements  with such
personnel mandating non-disclosure and prohibiting competition with the Company,
but there can be no assurance  that such  provisions  will be enforceable in all
events.

COMPETITION

         Kerr-McGee is the only other  manufacturer  of AP in the United States,
and currently  claims an annual  capacity of  approximately  36,000,000  pounds.
Kerr-McGee  has  in  the  past  produced  more  AP  than  the  Company  and  has
substantially greater financial resources. The pricing and procurement practices
of the  principal AP  customers  that have been in effect for over 10 years were
formulated  to  support  more  than one  United  States  producer  of AP.  These
practices  have  resulted in a  negotiated  price for the bulk of the  Company's
product based on settled  margins above fully allocated  costs.  The Company has
maintained  close  communication  with  its  principal  customers  and  with the
relevant governmental agencies for the purpose,  among other things, of enabling
management to assess, on a continuing basis,  future product demand and customer
satisfaction and to maintain the Company's market share. The Company has entered
into  long-term  pricing  agreements  for AP with its major  customers  that are
contingent  upon  the  closing  of  the  Agreement  with  Kerr-McGee  and,  on a
continuing  basis,  that  will be  contingent  upon  agreement  on the  terms of
specific purchase orders.

AGREEMENT WITH KERR-MCGEE

         On October 10, 1997, the Company,  through AMPAC,  Inc., a wholly owned
subsidiary,  entered into the Agreement with  Kerr-McGee,  pursuant to which the
Company  agreed to acquire and Kerr-McGee  agreed to sell certain  process data,
technical information,  customer lists, marketing contacts and related expertise
of Kerr-McGee  related to its production of AP (the "Assets") and  substantially
all the business of Kerr-McGee relating to the Assets and to the manufacture and
sale of AP (the  "Acquisition")  for a purchase price of $39,000,000.  Under the
Agreement,  the Company will also  acquire an option (the  "Option") to purchase
all or any portion of the inventory of AP stored at Kerr-McGee's premises on the
Closing  Date of the  Acquisition  (the  "Closing  Date")  and not  owned by, or
identified to a firm order from, a Kerr-McGee  customer (the  "Inventory").  The
Option is exercisable from time to time within the 12 month period commencing on
the  Closing  Date (the  "Option  Period").  The  Acquisition  does not  include
Kerr-McGee's  production facilities (the "Production  Facilities"),  and certain
related water and power supply  agreements  used by Kerr-McGee in the production
of AP. Under the  Agreement,  Kerr-McGee  has agreed to cease the production and
sale of AP,  except  under  certain  limited  circumstances  provided for in the
Agreement.  The Production  Facilities may continue to be used by Kerr-McGee for
production of AP under such circumstances.  Under the Agreement,  Kerr-McGee has
reserved  a  perpetual,  royalty  free,  nonexclusive  license to use any of the
technology  forming  part of the  Assets as may be  necessary  or useful to use,
repair or sell the Production Facilities (the "Reserved License").

         Under the Agreement,  Kerr-McGee also reserves the right (the "Reserved
Rights") to produce and sell AP (i) to fulfill  orders  scheduled  for  delivery
after the  closing,  subject to making  payments to the Company  with respect to
such orders as  provided in the  Agreement,  and (ii) in certain  other  limited
circumstances,  including  the Company's  inability to meet  customer  demand or
requirements, failure to exercise the Option in full or breach of the Agreement.


                                        6


<PAGE>
         The  Agreement  provides  that,  together  with the  Reserved  License,
Kerr-McGee is freely permitted in its discretion to (i) lease, sell,  dismantle,
demolish  and/or  scrap all or any portion of the  Production  Facilities,  (ii)
retain the Production Facilities for manufacture of Reclaimed Product, and (iii)
maintain the Production  Facilities in a "standby" or "mothballed"  condition so
they will be capable of being used to produce AP under the limited circumstances
referred to above.

         The Company's  obligation  to close under the Agreement is  conditioned
upon:  the  accuracy of  Kerr-McGee's  representations  therein;  compliance  by
Kerr-McGee  with its  obligations  thereunder;  the absence of material  adverse
change  impairing  the Assets or  Kerr-McGee's  AP  Business;  the  closing of a
financing  in an amount at least equal to the  purchase  price for the Assets of
$39,000,000;  and the conclusion by the Company of a long-term  supply agreement
with its major  customers  for the sale and purchase of AP, if the  existence of
such an agreement is  determined by the Company in good faith to be necessary to
obtain customer acquiescence to the Acquisition.

         Kerr-McGee's  obligation  to close under the  Agreement is  conditioned
upon: the accuracy of the Company's  representations therein;  compliance by the
Company with its obligations thereunder; receipt of a guaranty by the Company of
its  subsidiary's  obligations  under  the  Agreement;  and  the  conclusion  by
Kerr-McGee  of an  agreement  with NASA  and/or  Thiokol to hold the  Production
Facilities in a standby status for production of AP, if the existence of such an
agreement is  determined  by  Kerr-McGee in good faith to be necessary to obtain
their acquiescence or to facilitate a favorable review of the Acquisition by the
Federal   Trade   Commission   ("FTC")  or   Department  of  Justice  under  the
Hart-Scott-Rodino   Antitrust  Improvements  Act  (the  "H-S-R  Act")  or  other
applicable law.

         The  obligation  of each of the parties to close under the Agreement is
further  conditioned upon:  submission by both parties of notification under the
H-S-R Act and either the waiting  period  under the Act having  expired  with no
adverse action having been taken or requests for further information having been
received,  or  action on the  notification  deemed  satisfactory  by each of the
parties having been received; the Closing of the Acquisition not constituting or
causing a violation of any  applicable  covenant or  condition  contained in any
contract to which either party is bound; approval of the Closing and all related
actions  by the  board  of  directors  of  each  party,  and  by the  respective
managements and boards of directors of their parent  companies;  conclusion of a
long-term supply agreement between the parties whereby  Kerr-McGee would provide
sodium chlorate as a raw material to the Company,  if the parties mutually agree
that such long-term supply  agreement is necessary for successful  completion of
the  transactions  contemplated  by  the  Agreement;  absence  of  any  suit  or
proceeding threatened or pending which seeks to restrain, prohibit, challenge or
obtain damages or other relief in connection  with the Agreement or consummation
of the Acquisition;  and receipt by each party of an opinion from its respective
counsel that consummation of the Acquisition will not result in violation of any
applicable law.

         In December 1997, the Company  received  notification  that the FTC had
determined  to grant early  termination  of the waiting  period  relating to the
Company's  and  Kerr-McGee's  premerger  notification  filings  with the FTC and
Department of Justice.




                                        7


<PAGE>
SODIUM AZIDE

SODIUM AZIDE FACILITY

         In  July  1990,  the  Company   entered  into  agreements  (the  "Azide
Agreements")  pursuant to which  Dynamit Nobel has licensed to the Company on an
exclusive basis for the North American  market its most advanced  technology and
know-how for the production of sodium azide, the principal  component of the gas
generant used in certain automotive airbag safety systems. In addition,  Dynamit
Nobel has provided technical support for the design, construction and startup of
the facility.  The facility was constructed on land owned by the Company in Iron
County, Utah for its owner and operator,  American Azide Corporation  ("AAC"), a
wholly-owned  indirect  subsidiary  of the  Company,  and has an  annual  design
capacity of 6,000,000 pounds.

         Dynamit Nobel is an established  German firm engaged in the manufacture
of  explosives  and  detonators,   specialty  chemicals,  defense  technologies,
ammunition,  plastics  and  composites.  It  is  the  developer  of  the  sodium
metal-based   process  used  in  the  manufacture  of  sodium  azide,   and  has
successfully  utilized  the  process  on a  commercial  basis for over 80 years,
although on a much smaller scale than as practiced by the Company.

FINANCING

         On February 21, 1992, the Company concluded a $40,000,000 financing for
the design,  construction  and startup of the sodium azide facility  through the
sale of the Azide  Notes.  The  funds  were  provided  by a major  state  public
retirement fund and an investment  management  company.  The Azide Notes provide
for the semi-annual payment in arrears of interest at the rate of 11% per annum.
Principal is to be amortized to the extent of  $5,000,000  on each of the fourth
through  ninth  anniversary  dates of funding,  with the  remaining  $10,000,000
principal  amount to be repaid on the tenth  anniversary  date. At September 30,
1997, $10,000,000 principal amount of the Azide Notes had been repaid. The Azide
Notes are  secured by the fixed  assets and stock of AAC as well as by a deed of
trust on certain land in Clark  County,  Nevada being  developed by the Company.
The Company  issued  Warrants  ("the  Warrants") to the  purchasers of the Azide
Notes, which are exercisable for a 10-year period on or after December 31, 1993,
to purchase  shares of the  Company's  Common Stock.  The exercise  price of the
Warrants is $14.00 per share.  At a $14.00 per share exercise  price,  2,857,000
shares could be purchased under the Warrants.  The Warrants  contain  additional
provisions  for a  reduction  in  exercise  price in the event that the  Company
issues or is deemed to issue  stock,  rights to stock or  convertible  debt at a
price less than the exercise  price in effect,  or in the event of certain stock
dividends or in the event of stock splits, mergers or similar transactions.  The
terms of the  Warrants  permit  their  exercise  by  delivery to the Company for
cancellation of a principal amount of the Azide Notes equivalent to the exercise
price of the Warrants  being  exercised.  The Warrants are  exercisable,  at the
option of their  holders,  to  purchase  up to 20% of the  Common  Stock of AAC,
rather than the Company's  Common Stock.  In the event of such an election,  the
exercise  price of the  Warrants  will be based  upon a pro rata  share of AAC's
capital,  adjusted  for  earnings  and losses,  plus  interest  from the date of
contribution.

         The Indenture  under which the Azide Notes were issued imposes  various
operating  restrictions  upon the  Company,  including  restrictions  on (i) the
incurrence  of debt;  (ii) the  declaration  of  dividends  and the purchase and
repurchase of stock; (iii) certain mergers and consolidations,  and (iv) certain
dispositions of assets.  Management believes the Company has complied with these
operating restrictions.




                                        8


<PAGE>
         On each of December  31, 1995,  1997 and 1999,  holders of the Warrants
have the right to put to the  Company  as much as  one-third  thereof  at prices
determined  by the Company's  fully diluted  earnings per share and multiples of
13, 12 and 11  respectively,  but the  Company's  obligation  in such respect is
limited to $5,000,000 on each of such dates and to $15,000,000 in the aggregate.
Such put rights may not be exercised if the Company's Common Stock has traded at
values  during the  preceding  90-day  period  that would  yield to the  warrant
holders  a 25%  per  annum  internal  rate  of  return  to the  date  of the put
(inclusive of the Azide Notes'  yield).  On or after  December 31 of each of the
years 1995 through 1999,  the Company may call up to 10% of the Warrants (but no
more than 50% in the aggregate) at prices that would provide a 30% internal rate
of return to the  holders  thereof  through the date of call  (inclusive  of the
Azide Notes' yield).  The holders of the Warrants were also granted the right to
require that the Common Stock  underlying  the Warrants be registered  under the
Securities  Act of  1933,  as  amended,  on one  occasion,  as well  as  certain
incidental registration rights.

MARKET

         A number of firms have devoted  extensive efforts for at least 25 years
to the  development  of  automotive  airbag safety  systems.  These efforts have
resulted in the acceptance by the automobile  industry and the consuming  public
of  an  inflator  for  automotive  airbags  that  historically  has  been  based
principally  upon sodium azide,  combined in tablet or granule form with limited
amounts  of  other  materials.  Therefore,  the  majority  of  all  commercially
developed  automotive  airbag systems  installed to date  incorporate  inflation
technology  based on the use of the sodium azide.  Other  inflator  technologies
have been developed and are achieving market acceptance.

         The  Company  expects  demand for airbag  systems in North  America and
worldwide to increase  significantly over the next 10 years.  However, the level
of demand for  sodium  azide  will  depend,  in part,  upon the  penetration  of
competing inflator technologies that are not based upon the use of sodium azide.
Based principally upon market information received from inflator  manufacturers,
the Company  expects sodium azide use to decline and that inflators using sodium
azide will ultimately be phased out.

         The Company  previously  believed that demand for sodium azide in North
America and the world would substantially exceed existing manufacturing capacity
and announced expansions or new facilities (including the AAC plant) by the 1994
model year  (which for sodium  azide  sales  purposes  was the period  June 1993
through May 1994). Currently, demand for sodium azide is substantially less than
supply on a worldwide basis. The Company believes this is the result of capacity
expansions  by existing  producers,  although  the  Company's  information  with
respect to competitors'  existing and planned capacity is limited.  There can be
no assurance  that other  manufacturing  capacities not now known to the Company
will  not  be  established.   By  reason  of  this  highly   competitive  market
environment,  and other  factors  discussed  below,  sodium  azide  prices  have
decreased significantly over the past several years.

         The Company  believes  that the price  erosion of sodium azide over the
past few years has been due, in part, to unlawful pricing procedures of Japanese
sodium azide  producers.  In response to such  practices,  in January 1996,  the
Company filed an antidumping  petition with the  International  Trade Commission
("ITC") and the Department of Commerce  ("Commerce").  In August 1996,  Commerce
issued a preliminary  determination  that Japanese  imports of sodium azide have
been sold in the  United  States at prices  that are  significantly  below  fair
value.  Commerce's  preliminary  dumping  determination  applied to all Japanese
imports  of  sodium  azide,   regardless  of  end-use.   Commerce's  preliminary
determination followed a March 1996 preliminary determination by ITC that dumped
Japanese imports have caused material injury to the U.S. sodium azide industry.



                                        9
<PAGE>

         On  January  7,  1997  the  anti-dumping   investigation  initiated  by
Commerce,  based  upon  the  Company's  petition,  against  the  three  Japanese
producers  of sodium  azide was  suspended  by  agreement.  It is the  Company's
understanding  that,  by reason of the  Suspension  Agreement,  two of the three
Japanese sodium azide producers have ceased their exports of sodium azide to the
United States for the time being.  As to the third and largest  Japanese  sodium
azide  producer,  which  has  not  admitted  any  prior  unlawful  conduct,  the
Suspension  Agreement  requires  that it make all necessary  price  revisions to
eliminate all United  States sales at below "Normal  Value," and that it conform
to the  requirements  of  sections  732 and 733 of the  Tariff  Act of 1930,  as
amended,  in  connection  with its  future  sales of sodium  azide in the United
States.

         The Suspension  Agreement  contemplates a cost-based  determination  of
"Normal Value" and establishes  reporting and verification  procedures to assure
compliance. Accordingly, the minimum pricing for sodium azide sold in the United
States by the remaining  Japanese producer will be based primarily on its actual
costs, and may be affected by changes in the relevant exchange rates.

         Finally, the Suspension Agreement provides that it may be terminated by
any party on 60 days' notice,  in which event the anti-dumping  proceeding would
be  re-instituted  at the  stage  to  which  it had  advanced  at the  time  the
Suspension Agreement became effective.

CUSTOMERS

         The two major  suppliers of airbag  inflators in the United  States are
TRW and Autoliv ASP, Inc. ("Autoliv") (formerly Morton International  Automotive
Safety  Products).  AAC has received  notification that sodium azide produced at
its Utah plant is qualified  for use in most sodium azide based airbag  inflator
products of Autoliv and TRW. In May 1997, the Company  entered into a three-year
agreement  with Autoliv  which  provides for the Company to supply  sodium azide
used by Autoliv in the manufacture of automotive  airbags.  Deliveries under the
agreement  commenced in July 1997. The estimated sales value of the agreement is
approximately  $45 - $55 million over the  three-year  period.  The actual sales
value, however, will depend upon many factors beyond the control of the Company,
such as the number of automobiles and light trucks  manufactured and competitive
conditions in the airbag  market,  that will  influence the actual  magnitude of
Autoliv's sodium azide requirements,  and there can therefore be no assurance as
to the actual sales value of the contract.

COMPETITION

         The Company  believes  that a Canadian  facility is currently  the sole
competing  producer of sodium azide in commercial  quantities in North  America.
Dynamit Nobel in Germany,  one producer in Japan and two producers in India also
currently produce sodium azide. It is possible that domestic or foreign entities
will seek to develop  additional  sodium azide  production  facilities  in North
America. It is also possible that other inflator  technologies,  either existing
or not yet fully developed or identified,  will achieve significant market share
and  consequently  reduce  demand for sodium  azide.  The  Company's  plans with
respect to its sodium  azide  project  continue to be grounded in the  Company's
objective to become the major  supplier to the North  American  airbag  inflator
market,  but there can be no assurance of its ability to achieve this goal or of
future levels of demand for sodium azide.

         The Company has  incurred  significant  operating  losses in its sodium
azide  operation  during the last three fiscal years.  Sodium azide  performance
improved in the fourth quarter of fiscal 1997, principally as


                                       10
<PAGE>
a result of  additional  sodium  azide  deliveries  under the Autoliv  agreement
referred to above,  and the operations  were cash flow positive  during the year
ended  September  30,  1997.   However,   even  though   performance   improved,
Management's view of the economics of the sodium azide market changed during the
fourth  quarter of fiscal 1997. One major  inflator  manufacturer  announced the
acquisition of non-azide based inflator  technology and that they intended to be
in the market with this new technology by model year 1999. In addition, although
the Company has achieved significant gains in market share that appear to relate
to the Company's anti-dumping petition and the Suspension Agreement,  Management
believes  that the  effects  of the  anti-dumping  petition  were  likely  fully
incorporated into the sodium azide market by the end of fiscal 1997. Recognizing
that the  uncertainties  respecting  the market and discussed  above continue to
exist, during the fourth quarter of fiscal 1997,  Management  concluded that the
cash flows  associated with sodium azide  operations  would not be sufficient to
recover the Company's investment in sodium azide related fixed assets. As quoted
market prices were not  available,  the present  value of estimated  future cash
flows was used to estimate  the fair value of sodium azide fixed  assets.  Under
the  requirements of Statement of Financial  Accounting  Standards  ("SFAS") No.
121,  and as a result  of this  valuation  technique,  an  impairment  charge of
$52,605,000 was recognized in the fourth quarter of fiscal 1997.

AZIDE AGREEMENTS

         Under the Azide Agreements,  Dynamit Nobel was to receive,  for the use
of its  technology  and  know-how  relating to its batch  production  process of
manufacturing  sodium azide,  quarterly  royalty payments of 5% of the quarterly
net  sales of  sodium  azide by AAC for a period  of 15 years  from the date the
Company begins to produce sodium azide in commercial  quantities.  In July 1996,
the Company and Dynamit Nobel agreed to suspend the royalty payment effective as
of July 1, 1995. As a result,  in the third quarter of fiscal 1996,  the Company
recognized  an increase in sodium azide sales of  approximately  $600,000.  This
amount had previously  been  recognized as a reduction of net sodium azide sales
during the period July 1, 1995 through June 30, 1996.

HALOTRON

         Halotron is a fire suppression  system,  including a series of chemical
compounds and application  technologies,  designed to replace halons,  chemicals
presently in wide use as fire suppression  agents in military,  industrial,  and
commercial applications.  The impetus for the invention of Halotron was provided
by the  discovery  during the 1980s that  halons are highly  destructive  to the
stratospheric  ozone  layer,  which  acts  as a  shield  against  harmful  solar
ultraviolet  radiation.  A reduction in stratospheric  ozone is believed to have
the  potential  to result in long-term  increases in skin cancer and  cataracts,
suppression  of the  human  immune  system  and  damage  to  crops  and  natural
ecosystems. As a result of disclosures concerning the various halon compounds in
use, the Montreal  Protocol on  Substances  that Deplete the Ozone Layer,  which
became  effective in 1989 and was  strengthened in 1992 and 1996,  froze at 1986
levels the  production  of halons,  imposed a  phase-out  of the  production  of
halons, and completely banned production of halons as of December 31, 1995.

USE OF HALONS

         Halons  are used  throughout  the world in  modalities  that range from
hand-held fire extinguishers to extensively  engineered aircraft  installations,
but which are generally of two types, streaming and flooding systems.  Streaming
systems  rely upon the  focused  projection  of a slowly  gasifying  liquid over
distances  of up to 50 feet  from the  point  of  projection.  Flooding  systems
release a quickly  gasifying  liquid into a confined  space,  rendering  inert a
combustible atmosphere and extinguishing any ongoing combustion.


                                       11


<PAGE>
Halon 1211,  principally  a streaming  agent,  is used on aircraft  and aircraft
flightlines,  on small  boats  and  ships  and in  chemically  clean  rooms  and
laboratories, other commercial and industrial facilities, including those in the
lumber  and  petroleum  industries,   offices  and  residences.   Its  worldwide
production  peaked in 1988 at 19,000  metric  tons.  Halon 1301,  principally  a
flooding  agent,  protects  such  installations  as  computer,   electronic  and
equipment rooms, ship and other engine room spaces,  petroleum handling stations
and repositories of literature and cultural heritage.  Its worldwide  production
peaked in 1988 at 12,500 metric tons.

POTENTIAL CUSTOMERS

         The end-user market for halons and consequently,  Halotron,  is divided
into several segments. The government segment consists of the armed services and
other  agencies,  including  the  Department  of Energy,  NASA and  governmental
offices,  laboratories  and  data  processing  centers.  Historically,  military
applications have predominated in this segment,  and it is the military that has
taken the lead in research  for halon  replacements,  both in  streaming  and in
flooding  applications.  It will be critical to the Company's  efforts to market
Halotron to the military that military  specifications  for the  procurement  of
halon  replacements  include Halotron.  The Company is not aware of any military
specifications for halon replacements that have been issued to date.

         Commercial  market  segments  include fire critical  industries such as
utilities,  telecommunications firms, the oil and gas exploration and production
industry,  lumbering,  ocean  transport and  commercial  aviation.  Other market
segments  include other  business  organizations  and small users that typically
follow selections made by the industry users described above.

         Halotron  I, the first  phase of  Halotron,  has been  extensively  and
successfully  tested.  Halotron I is designed to replace halons in streaming and
in limited flooding  applications.  Halotron II is intended to replace halons in
flooding applications. Succeeding Halotron phases, if designed, will be intended
to supersede earlier Halotron phases,  generally on an optimized  application by
application  basis,  and will be  intended  to meet  more  strict  environmental
constraints expected to be applied in the future.

         The  Company's  efforts  to  produce,  market  and sell  Halotron I and
Halotron  II  are  dependent  upon  the  political   climate  and  environmental
regulations  that exist and may vary from country to country.  The  magnitude of
future  orders  received,  if any,  will be  dependent  to a large  degree  upon
political issues and environmental regulations that are not within the Company's
control,   as  well  as  additional   testing  and   qualification   in  certain
jurisdictions,  governmental  budgetary  constraints  and  the  ultimate  market
acceptance of these new products.

MARKET FOR HALOTRON

         In 1993, Halotron I was approved by the Environmental Protection Agency
("EPA")  as a  halon  1211  replacement  agent  in  connection  with  the  EPA's
Significant New Alternatives  Policy ("SNAP").  During 1995 the Federal Aviation
Administration ("FAA") approved Halotron I as an acceptable airport firefighting
agent. The FAA concluded that Halotron I will suppress or extinguish fire in the
same manner as halon.

         In  addition,  the Company,  in concert  with  Buckeye  Fire  Equipment
Company, has successfully  completed  Underwriters  Laboratories (UL) fire tests
for six  sizes  of  portable  fire  extinguishers  using  Halotron  I.  Domestic
distribution of the Buckeye Halotron extinguisher line began in early 1996.


                                       12
<PAGE>
         In  September  1997,  the  Company  and Badger  Fire  Protection,  Inc.
("Badger")  began UL fire tests of a line of portable fire  extinguishers  using
Halotron I. Assuming final UL certifications  are received,  it is the Company's
understanding  that Badger expects to begin distribution of this line during the
first half of calendar 1998.  The Company is also marketing  Halotron I to other
fire extinguisher manufacturers.

         In August 1997, the Company  completed a study which concluded that the
market for halon substitutes anticipated by the Company when it entered into the
Halotron  business in 1992 has not  materialized  and that the market for "clean
gas" substitutes for Halon 1211 would remain substantially smaller than the peak
use in 1988.  Although  the study also  concluded  that the  Company's  Halotron
product could command a significant  percentage of this smaller than anticipated
market there can be no  assurance  in that  regard.  In order for the Company to
achieve and maintain market share for Halotron,  and a long term presence in the
industry, it may be necessary for the Company to expend considerable  additional
funds and effort in research and  development.  Although current Halotron phases
have an Ozone Depletion  Potential ("ODP") that is significantly lower than that
of halons and meets current  environmental  standards,  potential users of halon
replacements  may  eventually  require  a product  with zero ODP.  Environmental
standards may also be expected to mandate this result. Accordingly,  the product
life of current  Halotron  phases may be limited and the Company may be required
to produce  succeeding  Halotron  phases  that can meet  increasingly  stringent
standards.  There  can be no  assurance  that such  phases  will be  capable  of
production or that a competitor or competitors will not develop fire suppression
agents with comparable or superior qualities.

COMPETITION

         Potential  halon  alternatives  and  substitutes  will  compete  as  to
performance   characteristics,   environmental  effects  and  cost.  Performance
characteristics include throw ability, visibility after application,  after-fire
damage,  equipment  portability and  versatility,  low temperature  performance,
corrosion  probability,  shelf life and efficiency.  The  environmental  effects
include  ODP, GWP (global  warming  potential)  and  toxicity.  Potential  halon
substitutes  include water, carbon dioxide and a variety of chemicals in liquid,
foam and powder form. It is likely that competitors  producing  alternatives and
substitutes  will be larger,  will have  experience  in the  production  of fire
suppressing chemicals and systems and will have greater financial resources than
those available to the Company. In 1996 Dupont introduced a new alternative fire
extinguishing  agent called FE-36(TM),  which is intended to replace Halon 1211.
The Company has limited  information with respect to this agent, but understands
that SNAP  approval is currently  pending.  Dupont claims that  FE-36(TM)  meets
application,  performance,  toxicity and environmental standards as a Halon 1211
replacement. The Company expects that there will be several competitive products
in the same market as Halotron II.

HALOTRON AGREEMENT

         On  August  30,  1991,  the  Company  entered  into an  agreement  (the
"Halotron  Agreement")  with Jan Andersson and AB-Bejaro  Product,  granting the
Company  the option  (which was  exercised  in  February,  1992) to acquire  the
exclusive  worldwide  rights to  manufacture  and sell  Halotron.  The  Halotron
Agreement  provides  for  disclosure  to the  Company  of all  confidential  and
proprietary  information concerning Halotron I (see below), which, together with
testing  performed at independent  laboratories  in Sweden and the United States
and consulting  services that have been provided by its inventors,  was intended
to  enable  the  Company  to  evaluate  Halotron  I's  commercial   utility  and
feasibility.  In February 1992, the Company announced that a series of technical
evaluations and field tests conducted at the


                                       13
<PAGE>
University  of New Mexico had been positive and  equivalent  to the  performance
previously  reported in testing at the Swedish National Institute of Testing and
Standards  and the  University  of Lund in Sweden.  On February  26,  1992,  the
Company acquired the rights provided for in the Halotron Agreement,  gave notice
to that effect to the  inventors,  and exercised its option.  In addition to the
exclusive license to manufacture and sell Halotron I, the rights acquired by the
Company include rights under all present and future patents relating to Halotron
I  throughout  the  world,   rights  to  related  and  follow-on   products  and
technologies and product and technology  improvements,  rights to reclaim, store
and  distribute  halon and  rights to utilize  the  productive  capacity  of the
inventors'  Swedish  manufacturing  facility.  Upon exercise of the option,  the
Company paid the sum of $700,000 (the exercise price of $1,000,000, less advance
payments  previously  made)  and  became  obligated  to pay the  further  sum of
$1,500,000 in monthly  installments  of $82,000,  commencing in March 1992.  The
license  agreement  between the Company and the  inventors of Halotron I provide
for a royalty to the  inventors of 5% of the  Company's  net sales of Halotron I
over a period  of 15 years  (however,  see  below for a  discussion  of  certain
litigation that terminated the inventors' rights to royalties). In addition, the
Company entered into employment and consulting agreements with Mr. Andersson and
AB-Bejaro Product under which,  among other things,  Halotron II (see below) has
been developed.

         See Note 14 to the Notes to  Consolidated  Financial  Statements of the
Company for a discussion of litigation associated with the Halotron Agreement.

HALOTRON FACILITY

         The Company has designed and  constructed a Halotron  facility that has
an annual  capacity of at least 6,000,000  pounds,  located on land owned by the
Company  in Iron  Country,  Utah.  Under the  Halotron  Agreement,  the  Company
received the technical support of the inventors for the design, construction and
operation of the new facility.

REAL ESTATE DEVELOPMENT

         The Company owns a 320-acre  tract in Clark County,  Nevada,  and about
4,700 acres in Iron  County,  Utah.  The Nevada  tract is the site of the Gibson
Business Park and the Company's Ventana Canyon joint venture residential project
(see below).  The 4,700 acre Utah site is primarily  dedicated to the  Company's
growth and diversification.

         The Company maintains close ties with the Nevada Development Authority,
the  regional  agency  primarily   responsible  for  economic   development  and
diversification in Southern Nevada.  Local marketing is done through real estate
professionals and through business and organizational  ties. The Gibson Business
Park competes with several other industrial parks in the Las Vegas Valley,  some
of which offer comparable sites and amenities.  It also competes with industrial
parks in the Phoenix, Reno and Salt Lake City areas.

         During fiscal 1993, the Company contributed  approximately 240 acres of
its Clark County development  property to Gibson Ranch Limited Liability Company
("GRLLC"),   the  developers  of  Ventana  Canyon,  a  master-planned  community
primarily  residential in character.  The development property contributed had a
carrying value of  approximately  $12,300,000 at the date of contribution  which
was  transferred to Real Estate Equity  Investments.  The Company's  interest in
GRLLC is  assigned to secure the Azide  Notes.  An  unrelated  local real estate
development  group (the  "Developer")  contributed an adjacent 80 acre parcel to
GRLLC.  GRLLC is developing the 320-acre parcel as primarily a residential  real
estate


                                       14

<PAGE>

development.  Developer is the managing member of GRLLC and manages the business
conducted by GRLLC. Certain major decisions, such as increasing debt and changes
in the development plan or budget may be made only by a management  committee on
which the Company is equally  represented.  The profits and losses of GRLLC will
be split equally  between the Company and Developer after the return of advances
and  agreed  upon  values for  initial  contributions.  Ventana  Canyon is being
constructed and sold on a residential phase basis. Developer expects the project
to be completed and sold by the end of calendar year 2000.

         Each of the Company and Developer is obligated to loan to GRLLC,  under
a revolving  line of credit,  up to $2,400,000 at an annual  interest rate of 10
percent.  However,  Developer  will not be required  to advance  funds under its
revolving line of credit until the Company's line is exhausted. At September 30,
1996,  the Company had advanced all of its committed  amount under this line. In
November,  1995,  the Company  committed to advance an additional  $1,700,000 to
Developer.  Developer is required to advance any funds received to GRLLC.  Funds
advanced under this  additional  commitment  bear annual interest of 12 percent.
Total  advances  under these  commitments  were  $3,171,000  and  $2,828,000  at
September  30,  1997  and  1996.   Although   additional  advances  under  these
commitments are not currently contemplated, the Company expects to fund any such
advances through existing cash balances.

ENVIRONMENTAL PROTECTION EQUIPMENT

         The Company  designs,  manufactures and markets systems for the control
of noxious odors,  the  disinfection of waste water streams and the treatment of
sea  water.  Its  OdorMaster(TM)  systems  eliminate  odors from gases at sewage
treatment  plants,  composting sites and pumping stations and at chemical,  food
processing and other industrial plants. These systems, which use electrochemical
technology developed in the Company's specialty chemical operations,  chemically
deodorize  malodorous  compounds in  contaminated  air.  Sodium  hypochlorite is
generated  on-site  from  salt  brine  or  sea  water  by  circulation   through
electrolytic  cells.  Once  generated,  it is utilized  within a scrubber  tower
containing both a spray area and a packing  section to maximize  contact between
the scrubbing  solution and the  contaminated  air. Sodium  hypochlorite  reacts
chemically with the two most common air stream  contaminants,  hydrogen  sulfide
and  ammonia,  to  produce  non-noxious  gases,  water and salts.  The salts,  a
by-product  of  the  process,   are  then  used  to  produce  additional  sodium
hypochlorite   which  is  then  used  for  further  odor   treatment.   Advanced
OdorMaster(TM)  systems  place two or three  scrubber  towers in series to treat
complex odors,  such as those produced at sewage  composting  sites or in sewage
sludge conditioning systems. ChlorMaster(TM) Brine and Sea water systems utilize
a  similar  process  to  disinfect  effluent  at  inland  sewage  treatment  and
industrial plants and to control marine growths in condenser cooling and service
water at power and desalination plants and at oil drilling production facilities
on seacoasts and offshore.

         The Company's customers for its OdorMaster(TM)System are municipalities
and special  authorities  (and the  contractors who build the sewage systems for
such  municipalities and authorities) and plant owners. Oil and other industrial
companies are customers of its ChlorMaster(TM)systems.  Its systems are marketed
domestically by sales  representatives and overseas by sales representatives and
licensees.   The  Company  competes  both  with  companies  that  utilize  other
decontamination  processes  and those  that  utilize  technology  similar to the
Company's.  All are substantially larger than the Company. The Company's success
to date is derived  from the ability of its  products  both to  generate  sodium
hypochlorite on site and to decontaminate  effectively.  Its future success will
depend upon the  competitiveness  of its technology and the success of its sales
representatives and licensees.


                                       15
<PAGE>
The  backlog for  environmental  protection  equipment  at the end of the fiscal
years ending  September 30, 1997, 1996 and 1995 was  $2,400,000,  $1,800,000 and
$2,500,000, respectively.

INSURANCE

         The  Company's  insurance  currently  includes  property  insurance  at
estimated  replacement value on all of its facilities and business  interruption
insurance.  The Company also maintains liability insurance.  Management believes
that the nature and extent of the  Company's  current  insurance  coverages  are
adequate.  The Company has not  experienced  difficulty  obtaining the types and
amounts of insurance it has sought.























                                      15-A


<PAGE>
GOVERNMENT REGULATION

         As a supplier  to United  States  government  projects,  the Company is
subject to audit and review by the government of the negotiation and performance
of,  and  of  the  accounting  and  general  practice  relating  to,  government
contracts. Most of the Company's contracts for the sale of AP are in whole or in
part subject to the Federal Acquisition  Regulations ("FARS").  The Company's AP
costs are audited by its customers and by government  audit agencies such as the
United States Defense Contract Audit Agency. To date, such audits have not had a
material effect on the Company's results of operations or financial position.

ENVIRONMENT AND SAFETY

         In the  operation of its chemical  plants,  the Company is subject to a
number  of  environmental   constraints   relating  to  atmospheric   emissions,
industrial  effluent  and  operating  conditions.  The  Company has thus far met
successfully  all  requirements  imposed,  and does not  anticipate  any adverse
effects  from  existing  or  presently  foreseeable  statutes  and  regulations,
although  there  can be no  assurance  in this  regard,  particularly  since the
Company's  plants  are  subject  to  continued   compliance  with  the  changing
requirements of federal and state occupational safety and health  administration
regulations.  The  costs  of  compliance  with  applicable  requirements  were a
component of the AP and sodium azide plant financings.

         The imposition of environmental constraints is a positive factor in the
development   of  the  Company's   environmental   protection   activities.   As
environmental  awareness  continues to increase,  the Company  anticipates  that
these business activities will be enhanced.

         Although a number of states  have  adopted  laws and  regulations  that
place  environmental  controls  and zoning  restrictions  on real  estate,  such
regulations have not had a significant effect on the Company.


         Trace amounts of  perchlorate  chemicals  were  recently  found in Lake
Mead.  Clark  County,  Nevada,  where Lake Mead is situated,  is the location of
Kerr-McGee's AP operations,  and was the location of the Company's AP operations
until May 1988. The Company is cooperating  with State and local  agencies,  and
with Kerr-McGee and other interested  firms, in the investigation and evaluation
of the source or sources of these trace amounts, possible environmental impacts,
and potential  remediation  methods.  Until these investigations and evaluations
have reached appropriate conclusions, it will not be possible for the Company to
determine  the extent to which,  if at all,  the  Company  may be called upon to
contribute or assist with future remediation  efforts, or the financial impacts,
if any, of such contributions or assistance.

         The Company has one major  operating  facility  (producing  perchlorate
chemicals,  sodium  azide,  Halotron  and  environmental  protection  equipment)
located  in Iron  County,  Utah.  The loss or  shutdown  of  operations  over an
extended  period of time at all or part of such  facility  would have a material
adverse effect on the Company. The Company's operations are subject to the usual
hazards  associated  with  chemical  manufacturing  and the related  storage and
transportation of products and wastes,  including explosions,  fires,  inclement
weather  and  natural  disasters,   mechanical  failure,  unscheduled  downtime,
transportation  interruptions,  chemical spills, discharges or releases of toxic
or hazardous substances or gases and other environmental risks, such as required
mediation of contamination.  These hazards can cause personal injury and loss of
life,   severe  damage  to  or   destruction   of  property  and  equipment  and
environmental  damage,  and may  result  in  suspension  of  operations  and the
imposition  of civil or  criminal  penalties.  The Company  maintains  property,
business interruption and casualty insurance at levels which it



                                       16


<PAGE>

believes are in accordance with customary industry practice, but there can be no
assurance  that the Company will not incur  losses  beyond the limits or outside
the coverage of its insurance.

         On May 4, 1988, the former  manufacturing  and office facilities of the
Company in Henderson,  Nevada were  destroyed by a series of massive  explosions
and  associated  fires  (the "May 1988  Incident").  Extensive  property  damage
occurred both at the Company's facilities and in immediately adjacent areas, the
principal  damage occurring  within a three-mile  radius.  Production of AP, the
Company's  principal  business,  ceased  for  a  15-month  period.   Significant
interruptions  were also  experienced in the Company's other  businesses,  which
occupied the same or adjacent  sites.  While the Company's  current  facility is
designed to site particular  components of the manufacturing process in discrete
areas of the facility and incorporates  modern equipment and materials  handling
systems designed,  constructed and operated in accordance with the operating and
safety  requirements  of  the  Company's   customers,   insurance  carriers  and
governmental authorities,  there can be no assurance that another incident could
not interrupt some or all of the activities  carried on at the Company's current
manufacturing site.

EMPLOYEES

         At September 30, 1997, the Company employed  approximately  200 persons
in executive,  administrative,  sales and manufacturing capacities.  The Company
considers relationships with its employees to be satisfactory.


ITEM 2. PROPERTIES

         The  following  table  sets forth  certain  information  regarding  the
Company's properties at September 30, 1997.
<TABLE>
<CAPTION>

                                                                    Approximate
                                                                      Area or                                  Approximate
    Location                     Principal USe                      Floor Space              Status            Annual Rent
    --------                     -------------                      -----------              ------            -----------
<S>                          <C>                                   <C>                      <C>                  <C>
Iron County, UT              AP  Manufacturing                       217 acres                Owned                ___
                             Facility (1)

Iron County, UT              Sodium Azide                             41 Acres                Owned(3)             ___
                             Manufacturing Facility (2)

Iron County, UT              Halotron Manufacturing(5)             6,720 sq. ft.              Owned                ___
                             Facility


Las Vegas, NV                Executive Offices:                    22,262 sq. ft.            Leased(4)           $550,000
                             American Pacific
                             Corporation, Real Estate
                             Division
</TABLE>

(1)      This  facility,  used  for  the  production  of  perchlorate  products,
         consists of  approximately  112,000  sq. ft. of enclosed  manufacturing
         space,  a 12,000 sq. ft.  administration  building  and a 3,200 sq. ft.
         laboratory  building.  Capacity  utilization  rates for the  production
         facility  were  approximately  34%, 38% and 60% during the fiscal years
         ended September 30, 1997, 1996 and 1995, respectively.


                                       17


<PAGE>
(2)      This  facility is used for the  production of sodium azide and consists
         of  approximately   34,600  sq.  ft.  of  enclosed   manufacturing  and
         laboratory space.

(3)      The  sodium  azide  manufacturing  facility  and land upon  which it is
         situated  is subject to a deed of trust in favor of the  holders of the
         Azide Notes. Capacity utilization rates for this facility were 45%, 39%
         and 15% during the fiscal  years ended  September  30,  1997,  1996 and
         1995, respectively.

(4)      These facilities are leased from 3770 Howard Hughes Parkway  Associates
         Limited  Partnership  for an initial  term of 10 years  which  began on
         March 1, 1991 at a current annual rental of $550,000.

(5)      Capacity  utilization rates for the Halotron  production  facility were
         approximately  4% during the fiscal year ended  September  30, 1997 and
         less than 1% during the fiscal years ended September 30, 1996 and 1995.

         The Company's  facilities  are  considered by it to be adequate for its
         present needs and suitable for their current use.

         For information  with respect to real estate division  properties owned
         by the Company see "Business - Real Estate Development."  Substantially
         all land in Clark County, Nevada owned by the Company secures the Azide
         Notes and is subject  to a  mortgage  and deed of trust in favor of the
         Azide Note holders.












                                       18


<PAGE>
ITEM 7. MANAGEMENT'S  DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

OVERVIEW

         The  Company is  principally  engaged in the  production  of AP for the
aerospace and national defense industries. In addition, the Company produces and
sells sodium azide,  the primary  component of a gas generant used in automotive
airbag safety systems, and Halotron, a chemical used in fire suppression systems
ranging from portable fire extinguishers to airport firefighting  vehicles.  The
perchlorate,  sodium azide and Halotron  facilities are located on the Company's
property  in  Southern  Utah  and the  chemicals  produced  and  sold  at  these
facilities  collectively represent the Company's specialty chemical segment. The
Company's  other lines of business  include  the  development  of real estate in
Nevada and the production of environmental protection equipment, including waste
and seawater treatment systems.

         The Company has incurred net losses  during the last three fiscal years
and operating  losses during the fiscal year ended  September 30, 1997 and 1995.
As a result, pre-tax income has not been sufficient to recover interest charges.

         The  Company  believes  that  North  American  AP demand  is  currently
approximately  22 to 24 million pounds  annually.  However,  supply  capacity is
substantially  in  excess  of these  estimated  demand  levels.  In an effort to
rationalize  the economics of the existing AP market,  the Company  entered into
the Agreement with Kerr-McGee.  The Agreement contemplates that the Company will
acquire certain process data, technical  information,  customer lists, marketing
contracts,  and  related  expertise  used  by  Kerr-McGee  primarily  in  the AP
industry.  The Agreement  calls for a purchase price of $39 million,  and grants
the  Company the option to  purchase  limited AP  inventory  of  Kerr-McGee  for
additional consideration.

         Closing  of the  transaction  is  subject  to a number  of  conditions,
including  the  Company's  securing of  financing of 100 percent of the purchase
price and Board of Directors  approvals by both parties.  In December  1997, the
Company  received  notification  that  the FTC had  determined  to  grant  early
termination  of the waiting  period  relating to the Company's and  Kerr-McGee's
premerger  notification  filings with the FTC and the Department of Justice. The
Company has entered  into  long-term  pricing  agreements  for AP with its major
customers  that are  contingent  upon the closing of the  transaction  and, on a
continuing  basis,  that will be contingent  upon agreement on terms of specific
purchase orders.

         There  can be no  assurance  that  the  conditions  to  closing  of the
transaction will be satisfied, or that the transaction will close.

         Sales  and  Operating  Revenues.  Sales  of the  Company's  perchlorate
chemical  products,  consisting  almost  entirely  of AP  sales,  accounted  for
approximately  52%,  51% and 75% of  revenues  during  the  fiscal  years  ended
September 30, 1997, 1996 and 1995,  respectively.  In general,  demand for AP is
driven by a relatively  small number of DOD and NASA  contractors;  as a result,
any one individual AP customer usually accounts for a significant portion of the
revenues of AP manufacturers.  For example,  Thiokol accounted for approximately
35%,  47% and 71% of the  Company's  revenues  during  the  fiscal  years  ended
September 30, 1997, 1996 and 1995, respectively.


                                       22


<PAGE>
         Sodium  azide sales  accounted  for  approximately  30%, 28% and 12% of
sales during fiscal years ended September 30, 1997, 1996 and 1995, respectively.
Despite  these  relative   increases  in  revenue,   the  Company  has  incurred
significant operating losses in its sodium azide operation during the last three
fiscal years. Sodium azide performance  improved in the fourth quarter of fiscal
1997,  principally as a result of additional  sodium azide  deliveries under the
Autoliv agreement  referred to below, and the operations were cash flow positive
during the year ended  September  30,  1997.  However,  even though  performance
improved,  Management's view of the economics of the sodium azide market changed
during  the fourth  quarter  of fiscal  1997.  One major  inflator  manufacturer
announced the acquisition of non-azide  based inflator  technology and that they
intended to be in the market  with this new  technology  by model year 1999.  In
addition,  although the Company has achieved  significant  gains in market share
that appear to relate to the Company's  anti-dumping petition and the Suspension
Agreement,  Management  believes that the effects of the  anti-dumping  petition
were likely fully incorporated into the sodium azide market by the end of fiscal
1997.  Recognizing  that the  uncertainties  respecting the market and discussed
above continue to exist,  during the fourth  quarter of fiscal 1997,  Management
concluded that the cash flows  associated with sodium azide operations would not
be sufficient to recover the Company's  investment in sodium azide related fixed
assets.  As quoted  market  prices  were not  available,  the  present  value of
estimated  future cash flows was used to estimate the fair value of sodium azide
fixed assets.  Under the  requirements  of SFAS No. 121, and as a result of this
valuation technique, an impairment charge of $52.6 million was recognized in the
fourth quarter of fiscal 1997.

         Sales of Halotron  amounted to  approximately 4% of revenues during the
fiscal year ended  September  30, 1997 and less than 1% during the fiscal  years
ended September 30, 1996 and 1995.  Halotron is designed to replace  halon-based
fire suppression systems. Accordingly, demand for Halotron depends upon a number
of factors  including the  willingness  of consumers to switch from  halon-based
systems, as well as existing and potential governmental regulations.

         Real estate and related sales amounted to approximately  8%, 12% and 9%
of revenues  during the fiscal years ended  September  30, 1997,  1996 and 1995,
respectively.  The nature of real estate  development and sales is such that the
Company is unable reliably to predict any pattern of future real estate sales or
recognition of the equity in earnings of real estate ventures.

         Environmental  protection  equipment sales accounted for  approximately
6%, 7% and 4% of revenues during the fiscal years ended September 30, 1997, 1996
and 1995, respectively.

         Cost of Sales. The principal elements  comprising the Company's cost of
sales are raw materials,  electric power, labor,  manufacturing overhead and the
basis in the real estate sold.  The major raw  materials  used by the Company in
its production processes are graphite,  sodium chlorate,  ammonia,  hydrochloric
acid, sodium metal, and nitrous oxide.  Significant increases in the cost of raw
materials may have an adverse impact on margins if the Company is unable to pass
along such  increases to its  customers,  although all the raw materials used in
the  Company's  manufacturing  processes  have  historically  been  available in
commercial quantities, and the Company has had no difficulty obtaining necessary
raw materials.

         Raw  material,   electric  power  and  labor  costs  have  not  changed
significantly  in the past  three  fiscal  years.  The  costs of  operating  the
Company's  specialty chemical plants are, however,  largely fixed.  Accordingly,
the Company  believes  that the potential  additional AP sales volume  resulting
from the acquisition  from Kerr-McGee  should generate  significant  incremental
cash flow because of the  operating  leverage  associated  with the  perchlorate
plant.  However,  amortization of the costs  associated with the acquisition are
expected to amount to approximately $4.0 million annually.

                                       23


<PAGE>
         Operating  Expenses.  Operating  (selling,  general and administrative)
expenses  were $9.5 million,  $9.4 million and $11.2  million  during the fiscal
years ended  September 30, 1997,  1996 and 1995,  respectively.  The decrease in
1996 is primarily due to the Company's  implementation  of certain cost control,
containment and reduction measures.

         Income   Taxes.   The  Company's   effective   income  tax  rates  were
approximately  17% in fiscal 1997 and 34% during each of the fiscal  years ended
September 30, 1996 and 1995. The Company's  effective  income tax rate decreased
to 17% in  fiscal  1997 as a  result  of the  establishment  of a $10.1  million
deferred tax valuation  allowance.  The Company's  effective tax rate will be 0%
until the  Company's  net  operating  losses  expire or the  Company has taxable
income necessary to eliminate the need for the valuation  allowance.  See Note 7
to the Consolidated Financial Statements of the Company.

         Net Income (Loss). Although the Company's net income (loss) and diluted
net  income   (loss)  per  common  share  have  not  been  subject  to  seasonal
fluctuations,  they have been and are  expected  to  continue  to be  subject to
variations  from  quarter  to  quarter  and  year to year  due to the  following
factors, among others: (i) as discussed in Note 10 to the Consolidated Financial
Statements of the Company,  the Company may incur material legal and other costs
associated with certain  litigation and  contingencies;  (ii) the timing of real
estate and related  sales and equity  earnings  of real  estate  ventures is not
predictable;  (iii) the  recognition of revenues from  environmental  protection
equipment  orders not accounted for as long-term  contracts  depends upon orders
generated and the timing of shipment of the  equipment;  (iv)  weighted  average
common and common  equivalent  shares for  purposes of  calculating  diluted net
income  (loss) per common share are subject to  significant  fluctuations  based
upon  changed  in  the  market  price  of  the  Company's  Common  Stock  due to
outstanding warrants and options;  and (v) the magnitude,  pricing and timing of
AP, sodium azide, Halotron, and environmental  protection equipment sales in the
future is uncertain.

RESULTS OF OPERATIONS

FISCAL YEAR ENDED SEPTEMBER 30, 1997 COMPARED TO FISCAL YEAR ENDED SEPTEMBER 30,
1996

         Sales and Operating  Revenues.  Sales increased $1.6 million, or 4%, to
$44 million in fiscal 1997 from $42.4 million in fiscal 1996.  This increase was
attributable to increase sales in the Company's  specialty chemical  operations.
The increase in specialty  chemical sales was due principally to increased sales
of sodium azide as a result of the  agreement  referred to below and an increase
in Halotron  sales  resulting  from the continued  acceptance of Halotron in the
market.

         In May 1997,  the Company  entered  into a  three-year  agreement  with
Autoliv.  The contract  provides for the Company to supply  sodium azide used by
Autoliv in the manufacture of automotive airbags.  Deliveries under the contract
commenced  in  July  1997.  The  estimated   sales  value  of  the  contract  is
approximately  $45.0 -55.0 million over the three-year  period. The actual sales
value, however, will depend upon many factors beyond the control of the Company,
such as the number of automobiles and light trucks  manufactured and competitive
conditions in the airbag market,  which will  influence the actual  magnitude of
Autoliv's sodium azide requirements,  and there can therefore be no assurance as
to the actual sales value of the contract.

         Cost of Sales. Cost of sales increased $3.8 million,  or 12%, in fiscal
1997 to $36.4  million  from $32.6  million in fiscal  1996.  This  increase was
primarily due to increases in specialty chemical sales volumes.  As a percentage
of sales, cost of sales increased to 83% as compared to 77% in fiscal 1996.


                                       24

<PAGE>
This relative  increase was  principally  due to the decreases in average prices
for sodium azide and Halotron in response to competitive  factors.  Depreciation
expense is expected to decrease by approximately  $3.5 million in fiscal 1998 as
a result of the impairment charge described above.

         Operating  Expenses.  Operating  (selling,  general and administrative)
expenses increased $0.1 million, or 1%, in fiscal 1997 to $9.5 million from $9.4
million in fiscal 1996.

         Fixed Asset  Impairment  Charge.  The Company has incurred  significant
operating  losses in its sodium  azide  operations  during the last three fiscal
years.  Sodium azide performance  improved in the fourth quarter of fiscal 1997,
principally as a result of additional  sodium azide deliveries under the Autoliv
agreement  referred to above,  and the operations were cash flow positive during
the fiscal year ended  September  30, 1997.  However,  management's  view of the
economics of the sodium azide market  indicated  that the cash flows  associated
with sodium azide  operations  would not be  sufficient to recover the Company's
investment in sodium azide related  fixed assets.  Because  quoted market prices
were not available, the present value of estimated future cash flows was used to
estimate  the fair  value of  sodium  azide  related  fixed  assets.  Under  the
requirements  of SFAS No. 121, and as a result of this valuation  technique,  an
impairment  charge of $52.6  million  was  recognized  in the fourth  quarter of
fiscal 1997.

         Employee  Separation and Management  Reorganization  Costs.  During the
fourth quarter of fiscal 1997,  the Company  recognized a charge of $3.6 million
associated  with employee  separations and management  reorganization  costs. In
addition,  relocation costs of  approximately  $0.4 million were incurred in the
fourth  quarter of fiscal 1997.  The Company  expects  operating  expenses to be
approximately  $0.8 million to $1.0 million  lower in fiscal 1998 as a result of
these separations and relocations.

         Equity in Earnings of Real Estate Venture. During fiscal 1997 and 1996,
the Company  recognized its share of the equity in the Company's  Ventana Canyon
joint venture.  The Company's  equity in the earnings of the project amounted to
approximately  $0.2 million and $0.7 million,  respectively.  Profits and losses
are split  equally  between the Company  and its venture  partner,  a local real
estate development  company.  The venture's profits decreased during fiscal 1997
principally as a result of the sale of improved land zoned for an apartment site
to an outside developer during fiscal 1996.

         Segment  Operating  Income  (Loss).  Operating  income  (loss)  of  the
Company's industry segments during the fiscal years ended September 30, 1997 and
1996 was as follows:

                                        1997                1996
                                        ----                ----

Specialty chemicals                 $(55,227,000)       $  (879,000)
Environmental protection equipment          (659)          (249,000)
Real Estate                            1,624,000          2,069,000
                                    ------------        -----------
            Total                   $(54,262,000)       $   941,000
                                    ============        ===========

The  increase  in  operating  loss of the  specialty  chemical  segment  relates
principally  to the fixed asset  impairment  charge of $52.6  million  discussed
above. The increase in operating loss of the environmental  protection equipment
was primarily due to a reduction in revenues from $3.1 million in fiscal 1996 to
$2.4 million in fiscal 1997. The decrease in operating income of the real estate
segment was  attributable  to a decrease in revenues from $5.2 million in fiscal
1996 to $3.6 million in fiscal 1997.


                                       25


<PAGE>
         Interest and Other Income.  Interest and other income decreased to $1.1
million in fiscal 1997 from $1.4 million in 1996.  The decrease was  principally
due to lower average cash and cash equivalent balances.

         Interest and Other  Expense.  Interest and other  expense  decreased to
$2.0 million in fiscal 1997 from $2.8  million in fiscal  1996.  The decrease is
primarily due to a reduction in debt balances.

FISCAL YEAR ENDED SEPTEMBER 30, 1996 COMPARED TO FISCAL YEAR ENDED SEPTEMBER 30,
1995

         Sales.  Sales  increased  $3.2 million,  or 8%, in fiscal 1996 to $42.4
million from $39.2  million in fiscal 1995.  This increase was  attributable  to
increased  sales of sodium  azide  and real  estate  sales.  Such  increase  was
partially offset by a decrease in perchlorate sales.

         Under  certain  agreements  with  Dynamit  Nobel  (see  Note  13 to the
Consolidated Financial Statements of the Company), Dynamit Nobel was to receive,
for the use of its  technology  and  know-how  relating to its batch  production
process of manufacturing  sodium azide,  quarterly royalty payments of 5% of the
quarterly net sales of sodium azide by the Company for a period of 15 years from
the date the Company begins to produce sodium azide in commercial quantities. In
July 1996, the Company and

                                      25-A


<PAGE>
Dynamit  Nobel agreed to suspend the royalty  agreement  effective as of July 1,
1995. As a result,  in third quarter of fiscal 1996,  the Company  recognized an
increase in sodium azide sales of  approximately  $0.6 million.  This amount had
previously  been  recognized as a reduction of net sodium azide sales during the
period of July 1, 1995 through June 30, 1996.

         In 1994,  the  Company and Thiokol  executed  an  amendment  to certain
agreements  that  provided for the any to receive  revenues  from sales of AP of
approximately  $28.0  million and $20.0  million  during the fiscal  years ended
September  30,  1995 and  1996,  respectively.  See  Note 9 to the  Consolidated
Financial Statements of the Company.

         Cost of Sales.  Cost of sales increased $2.7 million,  or 9%, in fiscal
1996 to $32.6  million  from $29.9  million in fiscal  1995.  This  increase was
principally due to increased sodium azide sales volume and real estate sales. As
a percentage of sales, cost of sales increased in fiscal 1996 to 77% as compared
to 76% in the  corresponding  period of 1995. This increase was due to increased
depreciation  expense  associated  with sodium  azide  operations.  Depreciation
expense  increased  in the third  quarter  of fiscal  1995 as the  sodium  azide
facility completed its transition from construction to production activities. On
an  annualized  basis,  cost of sales  associated  with sodium azide  activities
increased by approximately  $3.0 million  beginning April 1, 1995 as a result of
this increase in depreciation expense.

         Operating  Expenses.  Operating  (selling,  general and administrative)
expenses  decreased  $1.8  million,  or 16%, in fiscal 1996 to $9.4 million from
$11.2  million in fiscal 1995.  The decrease is primarily  due to the  Company's
implementation of certain cost control,  containment and reduction measures.  In
addition,  during the third quarter of fiscal 1996, the Company  settled certain
matters  with its  insurance  carrier  relating  to legal  fees and other  costs
associated with the successful defense of certain  shareholder  lawsuits.  Under
this settlement,  the Company was reimbursed for  approximately  $0.5 million in
costs that had  previously  been expensed and incurred in  connection  with such
defense.  Such amount was recognized as a reduction in operating expenses in the
third  quarter  of  fiscal  1996.  See  Note  10 to the  Consolidated  Financial
Statements of the Company.

         During the third  quarter of fiscal  1995,  the Company  reduced  total
full-time  employee   equivalents  by  approximately  10%  through   involuntary
terminations  and  an  offering  of  enhanced  retirement  benefits  to  certain
employees. The Company recognized a charge to operating expense of approximately
$0.2 million as a result of these  terminations  and the acceptance of the offer
of enhanced retirement benefits by certain employees.

         Equity in Earnings  of Real Estate  Venture.  The  Company's  equity in
earnings of real estate  venture  amounted to $0 and $0.7 million for the fiscal
years ended 1995 and 1996, respectively.

         Segment  Operating  Income  (Loss).  Operating  income  (loss)  of  the
Company's industry segments during the fiscal years ended September 30, 1996 and
1995 was as follows:

                                        1997                1996
                                        ----                ----

Specialty chemicals                 $   (879,000)       $(2,150,000)
Environmental protection equipment      (249,000)          (640,000)
Real Estate                            2,069,000          1,356,000
                                    ------------        -----------
            Total                   $    941,000        $(1,434,000)
                                    ============        ===========

                                       26
<PAGE>
The increase in operating loss of the specialty  chemical  segment was primarily
attributable  to an increase  in sodium  azide sales as  discussed  above.  Such
decrease was partially offset by the increase in depreciation expense associated
with sodium azide  operations  referred to above. The decrease in operating loss
of the  environmental  protection  equipment  segment  was  primarily  due to an
increase in revenues  from $1.7 million in fiscal 1995 to $3.1 million in fiscal
1996.  The  increase  in  operating  income  of  the  real  estate  segment  was
attributable  to an increase  in sales from $3.4  million in fiscal 1995 to $5.2
million in fiscal 1996.

         Interest and Other  Income.  Interest and other income was $1.4 million
in fiscal 1996 and 1995.

         Interest and Other  Expense.  Interest and other  expense  increased to
$2.8 million in fiscal 1996 from $1.7  million in fiscal  1995.  The increase is
principally  due to the  cessation of interest  capitalization  on the Company's
sodium azide facility.

INFLATION

         Inflation did not have a significant  effect on the Company's sales and
operating  revenues or costs during the  three-year  period ended  September 30,
1997. The Company does not expect  inflation to have a material  effect on gross
profit in the future,  because  any  increases  in  production  costs  should be
recovered  through  increases  in  product  prices,  although  there  can  be no
assurance in that regard.

                                      26-A


<PAGE>
LIQUIDITY AND CAPITAL RESOURCES

         Cash flows  provided by operating  activities  were $9.6 million,  $4.4
million and $10.0 million during the fiscal years ended September 30, 1997, 1996
and 1995, respectively.  Cash flows from operating activities declined in fiscal
1996 and increased in fiscal 1997  principally as a result of changes in certain
working  capital  balances.  The  Company  believes  that  its cash  flows  from
operations  and existing  cash  balances  will be adequate  for the  foreseeable
future to  satisfy  the needs of its  operations.  However,  the  resolution  of
litigation and  contingencies,  and the timing,  pricing and magnitude of orders
for  AP,  sodium  azide  and  Halotron,  may  have  an  effect  on the  use  and
availability of cash.

         As a condition of the Agreement  with  Kerr-McGee,  the Company will be
required to obtain  financing for 100 percent of the purchase price. The Company
currently expects that such financing will be available on customary  commercial
terms, although there can be no assurance given with respect thereto.

         Capital  expenditures were $1.6 million,  $3.2 million and $4.5 million
during the fiscal years ended September 30, 1997,  1996 and 1995,  respectively.
Capital  expenditures  are expected to amount to  approximately  $2.5 million in
fiscal  1998 and  relate  principally  to  specialty  chemical  segment  capital
improvement  projects.  Capital  expenditures  are  expected  to be funded  from
existing cash balances and operating cash flow.

         During the  three-year  period  ended  September  30,  1997 the Company
repaid $12.2  million of debt,  repurchased  $1.0 million in treasury  stock and
issued $0.4 million in common  stock as a result of the exercise of  outstanding
stock options. The Azide Notes require annual principal payments of $5.0 million
through fiscal 2001 and a balloon payment of $10.0 million in fiscal 2002.

         As a result of the litigation and contingencies discussed in Note 10 to
the Consolidated  Financial  Statements of the Company, the Company has incurred
legal and other costs and may incur  material  legal and other costs  associated
with the resolution of these matters in future periods. Certain of the costs, if
any, may be reimbursable  under policies providing for insurance  coverage.  The
Company  has  adopted   certain   policies  in  its  Restated   Certificate   of
Incorporation , as amended,  and By-laws as a result of which the Company may be
required to indemnify its affected  officers and directors to the extent,  if at
all, that existing insurance coverages relating to the shareholder  lawsuits are
insufficient. The Company has in force substantial insurance covering this risk.
The Company's  insurance carriers have reserved the right to exclude or disclaim
coverage under certain circumstances. Defense costs and any potential settlement
or judgment costs associated with litigation, to the extent borne by the Company
and not  recovered  through  insurance,  would  adversely  affect the  Company's
liquidity.  The Company is currently unable to predict or quantify the amount or
range of such costs, if any, or the period of time that litigation related costs
will be incurred.

         The Company is  currently  in the process of  evaluating  its  computer
software  and  databases  to  determine  whether  or not  modifications  will be
required to prevent problems related to the Year 2000. These problems which have
been widely reported in the media,  could cause malfunctions in certain software
and  databases  with  respect  to dates  on or after  January  1,  2000,  unless
corrected.  Based upon its evaluation to date, the Company does not believe that
the costs of any  modifications  required to correct the Year 2000 problems will
have a material  impact on operations,  although there can be no assurance given
with respect thereto.


                                       27


<PAGE>
FORWARD-LOOKING STATEMENTS/RISK FACTORS

         Certain  matters  discussed  in  this  Report  may  be  forward-looking
statements that are subject to risks and  uncertainties  that could cause actual
results to differ materially from those projected.  Such risks and uncertainties
include, but are not limited to, the risk factors set forth below. The following
important risk factors,  among others, may cause the Company's operating results
and/or financial position to be adversely affected from time to time:

           1. Declining  demand or downward  pricing  pressure for the Company's
           products  as a result of general  or  specific  economic  conditions,
           further  governmental  budget  decreases  affecting the Department of
           Defense or NASA which would cause a continued  decrease in demand for
           AP, the results achieved by the Suspension  Agreement  resulting from
           the Company's  anti-dumping  petition and the possible termination of
           such  agreement,  technological  advances  and  improvements  or  new
           competitive  products causing a reduction or elimination of demand of
           AP, sodium azide or Halotron, the ability and desire of purchasers to
           change  existing  products  or  substitute  other  products  for  the
           Company's products based upon perceived quality and pricing,  and the
           fact that  perchlorate  chemicals,  sodium  azide,  Halotron  and the
           Company's environmental products have limited applications and highly
           concentrated customer bases.

           2. Competitive  factors including,  but not limited to, the Company's
           limitations respecting financial resources and its ability to compete
           against companies with substantially  greater resources,  significant
           excess  market  supply in the AP and  sodium  azide  markets  and the
           development or penetration of competing new products, particularly in
           the propulsion, airbag inflation and fire suppression businesses.

           3.  Underutilization  of  the  Company's   manufacturing   facilities
           resulting in  production  inefficiencies  and  increased  costs,  the
           inability to recover facility costs and reductions in margins.

           4.  Difficulties  in procuring  raw  materials,  supplies,  power and
           natural gas used in the production of perchlorates,  sodium azide and
           Halotron  products and used in the engineering  and assembly  process
           for environmental protection equipment products.

           5. The Company's ability to control the amount of operating  expenses
           and/or the impact of any  non-recurring  or unusual  items  resulting
           from the Company's  continuing  evaluation of its strategies,  plans,
           organizational structure and asset valuations.

           6.  Risks  associated  with the  Company's  real  estate  activities,
           including,  but  not  limited  to,  dependence  upon  the  Las  Vegas
           commercial,  industrial and residential real estate markets,  changes
           in general or local, economic conditions,  interest rate fluctuations
           affecting the availability and the cost of financing, the performance
           of the managing  partner of GRLLC (Ventana  Canyon Joint Venture) and
           regulatory and environmental  matters that may have a negative impact
           on sales or costs.

           7. The  effects  of,  and  changes  in,  trade,  monetary  and fiscal
           policies,  laws and regulations and other  activities of governments,
           agencies  or similar  organizations,  including,  but not limited to,
           environmental, safety and transportation issues.

           8. The cost and  effects  of legal  and  administrative  proceedings,
           settlements and investigations,  particularly those described in Note
           10 to the Notes to Consolidated  Financial  Statements of the Company
           and claims  made by or against  the  Company  relative  to patents or
           property rights.

                                       28

<PAGE>
           9. The adoption of new, or changes in existing,  accounting  policies
           and practices.

           10. Closing of the Agreement with Kerr-McGee.

           11. The dependence  upon a single facility for the production of most
           of the Company's products.


ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

         Financial  statements  called for hereunder are included  herein on the
         following pages:

                                                                      Page(s)

         Independent Auditors' Report                                   37

         Consolidated Balance Sheets                                    38

         Consolidated Statements of Operations                          39

         Consolidated Statements of Cash Flows                          40

         Consolidated Statements of Changes in Shareholders' Equity     41

         Notes to Consolidated Financial Statements                   42-60






                                      28-A

<PAGE>
                                     PART IV

ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K

(a)       (1)     FINANCIAL STATEMENTS

                  (a) See  Part  II,  Item  8  for  index  to  the  Registrant's
                      financial statements and supplementary data.

                  (b) Separate  audited  financial  statements  of Gibson  Ranch
                      Limited Liability Company as required under Regulation S-X
                      210. 3-09. See pages 61-69 herein.

          (2)     FINANCIAL STATEMENT SCHEDULES

                  None applicable.

          (3)     EXHIBITS

                  (a)    The following Exhibits are filed as part of this Report
                         (references are to Regulation S-K Exhibit Numbers):

          3.1     Registrant's    Restated    Certificate   of    Incorporation,
                  incorporated  by  reference  to  Exhibit  3A  to  Registrant's
                  Registration  Statement on Form S-14 (File No. 2-70830),  (the
                  "Form S-14").

          3.2     Registrant's By-Laws,  incorporated by reference to Exhibit 3B
                  to the Form S-14.

          3.3     Articles  of  Amendment  to  the   Restated   Certificate   of
                  Incorporation,  as filed with the Secretary of State, State of
                  Delaware,  on October 7, 1991,  incorporated  by  reference to
                  Exhibit 4.3 to Registrant's Registration Statement on Form S-3
                  (File No. 33-52196) (the "Form S-3").

          3.4     Articles  of  Amendment  to  the   Restated   Certificate   of
                  Incorporation  as filed with the Secretary of State,  State of
                  Delaware,  on April 21,  1992,  incorporated  by  reference to
                  Exhibit 4.4 to the Form S-3.

         10.1     Employment  agreement  dated  November  7,  1994  between  the
                  Registrant  and David N. Keys,  incorporated  by  reference to
                  Exhibit 10.22 of the 1994 10-K.

         10.2     Form of American Pacific  Corporation  Defined Benefit Pension
                  Plan,  incorporated  by  reference  to  Exhibit  10.21  to the
                  Registrant's  Registration  Statement  on Form S-2  (File  No.
                  33-36664) (the "1990 S-2").

         10.3     Lease Agreement between 3770 Hughes Parkway Associates Limited
                  Partnership   and  the   Registrant,   dated  July  31,  1990,
                  incorporated by reference to Exhibit 10.22 to the 1990 S-2.

         10.4     Limited   Partnership   Agreement   of  3770  Hughes   Parkway
                  Associates, Limited Partnership,  incorporated by reference to
                  Exhibit 10.23 to the 1990 S-2.


                                       31
<PAGE>

         10.5     Cooperation  and Stock  Option  Agreement  dated as of July 4,
                  1990 by and  between  Dynamit  Nobel  AG and  the  Registrant,
                  including  exhibits  thereto,  incorporated  by  reference  to
                  Exhibit 10.24 to the 1990 S-2.

         10.6     Stock Option  Agreement  between the  Registrant  and David N.
                  Keys dated  November  12, 1990  incorporated  by  reference to
                  Exhibit 19 to the  Registrant's  quarterly Report on Form 10-Q
                  for the fiscal quarter ended December 31, 1990.

         10.7     American Pacific  Corporation 1991  Nonqualified  Stock Option
                  Plan,  incorporated  by reference to Exhibit 10.26 to the 1990
                  S-2.

         10.8     Indenture dated February 21, 1992,  between the Registrant and
                  American Azide Corporation, a Nevada corporation, and Security
                  Pacific National Bank,  Trustee,  relating to the Registrant's
                  outstanding 11% Subordinated Secured Term Notes,  incorporated
                  by  reference  to  Exhibit  10.1 to the  Registrant's  Current
                  Report on Form 8-K dated February 28, 1992 (the "Form 8-K").

         10.9     Form of  Subordinated  Secured  Term Note dated  February  21,
                  1992, made by Registrant  Incorporated by reference to Exhibit
                  10.2 to the Form 8-K.

        10.10     Form of Note and Warrants  Purchase  Agreement  dated February
                  21, 1992,  relating to the Registrant's  Subordinated  Secured
                  Term Notes,  incorporated  by reference to Exhibit 10.3 to the
                  Form 8-K.

        10.11     Form of Warrant to  purchase  Common  Stock of the  Registrant
                  dated February 21, 1992,  incorporated by reference to Exhibit
                  10.4 to the Form 8-K.

        10.12     Form of Warrant to purchase  Common  Stock of  American  Azide
                  Corporation dated February 21, 1992, incorporated by reference
                  to Exhibit 10.5 to the Form 8-K.

        10.13     Stock  Option  Agreement  between  Registrant  and  Joseph  W.
                  Cuzzupoli dated January 30, 1992, incorporated by reference to
                  Exhibit 4.6 of Registrant's Registration Statement on Form S-8
                  (File No. 33-52898).

        10.14     Articles of  organization  of Gibson Ranch Limited - Liability
                  Company  dated August 25, 1993,  incorporated  by reference to
                  Exhibit 10.33 to the  Registrant's  Annual Report on Form 10-K
                  for the  fiscal  year  ended  September  30,  1993 (the  "1993
                  10-K").

        10.15     Operating  agreement  of  Gibson  Ranch  Limited  -  Liability
                  Company, a Nevada Limited - Liability Company, incorporated by
                  reference to Exhibit 10.34 to the 1993 10-K.

        10.16     American Pacific Corporation 1994 Directors' Stock Option Plan
                  incorporated by reference to Exhibit 10.34 to the Registrant's
                  Annual Report on Form 10-K for the fiscal year ended September
                  30, 1995 (the "1995 10-K").

        10.17     Stock  Option   Agreement   between   Registrant  and  General
                  Technical  Services,  Inc. dated July 11, 1995 incorporated by
                  reference to Exhibit 10.35 to the 1995 10-K.

                                       32


<PAGE>
        10.18     Stock Option Agreement  between  Registrant and John R. Gibson
                  dated July 8, 1997  incorporated by reference to Exhibit 10.18
                  to the Registrant's  Annual Report on Form 10-K for the fiscal
                  year ended September 30, 1997 (the "1997 10-K").

        10.19     Stock Option  Agreement  between  Registrant and David N. Keys
                  dated July 8, 1997  incorporated by reference to Exhibit 10.19
                  to the 1997 10-K.

        10.20     Settlement  Agreement  between  Registrant and C. Keith Rooker
                  dated July 17, 1997 incorporated by reference to Exhibit 10.20
                  to the 1997 10-K.

        10.21     Form of Stock Option Agreement between  Registrant and certain
                  Directors  dated May 21, 1997  incorporated  by  reference  to
                  Exhibit 10.21 to the 1997 10-K.

           22     Subsidiaries  of the Registrant  incorporated  by reference to
                  Exhibit 22 to the 1997 10-K.

          *23     Consent of Deloitte & Touche LLP.


           27     Financial Data Schedule  (previously filed electronically with
                  the 1997 10-K)

* FILED HEREWITH.

                  (b)      REPORTS ON FORM 8-K.

                           None.













                                       33


<PAGE>
                                   SIGNATURES

         Pursuant to the  requirements  of Section 13 or 15(d) of the Securities
and  Exchange  Act of 1934,  the  Registrant  has duly  caused this Report to be
signed on its behalf by the undersigned, thereunto duly authorized.

Dated: June 12, 1998        AMERICAN PACIFIC CORPORATION
                                           (Registrant)



                                By:/s/ John R. Gibson
                                   -------------------------------------------
                                   John R. Gibson
                                   President & Chief Executive Officer



                                By:/s/ David N. Keys
                                   -------------------------------------------
                                   David N. Keys
                                   Senior Vice President, Chief Financial
                                   Officer, Secretary and Treasurer, Principal
                                   Financial and Accounting Officer










                                       34


<PAGE>
INDEPENDENT AUDITORS' REPORT

To the Board of Directors of
American Pacific Corporation:

We have audited the accompanying consolidated balance sheets of American Pacific
Corporation  and its  Subsidiaries  (the "Company") as of September 30, 1997 and
1996,  and the related  consolidated  statements of  operations,  cash flows and
changes in shareholders'  equity for each of the three years in the period ended
September 30, 1997.  These financial  statements are the  responsibility  of the
Company's  management.  Our  responsibility  is to  express  an  opinion  on the
financial statements based on our audits.

We  conducted  our  audits  in  accordance  with  generally   accepted  auditing
standards.  Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

In our opinion,  such consolidated  financial  statements present fairly, in all
material  respects,  the financial position of the Company at September 30, 1997
and 1996,  and the results of its  operations and its cash flows for each of the
three years in the period ended  September 30, 1997 in conformity with generally
accepted accounting principles.


/s/ Deloitte & Touche LLP

DELOITTE & TOUCHE LLP

Las Vegas, Nevada
November 14, 1997


                                       37

<PAGE>
AMERICAN PACIFIC CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
SEPTEMBER 30, 1997 AND 1996

<TABLE>
<CAPTION>

                                                                       Notes             1997                    1996
                                                                   -----------------------------------------------------
ASSETS
CURRENT ASSETS:
<S>                                                                   <C>            <C>                    <C>         
   Cash and cash equivalents                                          1              $18,881,000            $ 18,501,000
   Short-term investments                                             1                                        2,000,000
   Accounts and notes receivable                                                       5,551,000               4,165,000
   Related party notes receivable                                     1                  637,000                 737,000
   Inventories                                                        1,2             11,116,000              11,297,000
   Prepaid expenses and other assets                                                     979,000                 946,000
                                                                                    ------------------------------------

     Total current assets                                                             37,164,000              37,646,000
PROPERTY, PLANT AND EQUIPMENT, NET                                    1,4,6,13,15     19,314,000              77,217,000
DEVELOPMENT PROPERTY                                                  1,5,6            7,362,000               8,631,000
RESTRICTED CASH                                                       3,6              3,580,000               4,969,000
REAL ESTATE EQUITY INVESTMENTS                                        5,6             20,248,000              18,698,000
DEBT ISSUE COSTS                                                      1                  785,000                 965,000
INTANGIBLE ASSETS                                                     14               1,540,000               1,760,000
OTHER ASSETS                                                                              88,000                 133,000
                                                                                    ------------------------------------
TOTAL ASSETS                                                                         $90,081,000            $150,019,000
                                                                                    ====================================
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
   Accounts payable and accrued liabilities                                          $ 7,519,000            $  5,407,000
   Notes payable and current portion of
     long-term debt                                                   3,6,9            6,166,000               7,334,000
                                                                                    ------------------------------------

     Total current liabilities                                                        13,685,000              12,741,000
LONG-TERM PAYABLES                                                    16              2,376,000
LONG-TERM DEBT                                                        3,6,9           24,900,000              29,452,000
DEFERRED INCOME TAXES                                                 1,7                                     10,101,000
                                                                                    ------------------------------------
TOTAL LIABILITIES                                                                     40,961,000              52,294,000
                                                                                    ------------------------------------

COMMITMENTS AND CONTINGENCIES                                         5,10,15
WARRANTS TO PURCHASE COMMON STOCK                                     6,11             3,569,000               3,569,000
SHAREHOLDERS' EQUITY:                                                 6,11
   Common stock - $.10 par value, 20,000,000 authorized:
     issued - 8,289,791 in 1997 and 8,228,791 in 1996                                    829,000                 823,000
     
   Capital in excess of par value                                     1               78,561,000              78,331,000
   Retained earnings (accumulated deficit)                            1              (32,707,000)             15,978,000
   Treasury stock (152,254 shares in 1997 and 130,170 shares in 1996) 1               (1,035,000)               (879,000)
   Note receivable from the sale of stock                             1,11               (97,000)                (97,000)
                                                                                    ------------------------------------
     Total shareholders' equity                                                       45,551,000              94,156,000
                                                                                    ------------------------------------
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY                                           $90,081,000            $150,019,000
                                                                                    ====================================
</TABLE>

See Notes to Consolidated Financial Statements.

                                       38
<PAGE>
AMERICAN PACIFIC CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE YEARS ENDED SEPTEMBER 30, 1997, 1996 AND 1995

<TABLE>
<CAPTION>

                                                      Notes            1997                  1996                1995
                                             -----------------------------------------------------------------------------

<S>                                            <C>                  <C>                   <C>                <C>
SALES AND OPERATING REVENUES                   1,9,12,13,15         $44,050,000           $42,381,000        $ 39,250,000
COST OF SALES                                  1,9,13,14             36,420,000            32,579,000          29,861,000
                                                                   ------------------------------------------------------
GROSS PROFIT                                                         7,630,000              9,802,000           9,389,000
OPERATING EXPENSES                             1,8,10,12,13,14,16    9,509,000              9,367,000          11,210,000
FIXED ASSET IMPAIRMENT CHARGE                  13                   52,605,000
EMPLOYEE SEPARATION AND MANAGEMENT                                                                                226,000
   REORGANIZATION COSTS                        16                    3,616,000
EQUITY IN EARNINGS OF REAL
   ESTATE VENTURE                              5                       200,000                700,000
                                                                   ------------------------------------------------------
OPERATING INCOME (LOSS)                                            (57,900,000)             1,135,000          (2,047,000)
INTEREST AND OTHER INCOME                      1,3,5,11              1,115,000              1,381,000           1,429,000
INTEREST AND OTHER EXPENSE                     1,5,6                 2,001,000              2,836,000           1,709,000
                                                                   ------------------------------------------------------
LOSS BEFORE CREDIT FOR INCOME TAXES                                (58,786,000)              (320,000)         (2,327,000)
CREDIT FOR INCOME TAXES                        1,7                 (10,101,000)              (109,000)           (791,000)
                                                                   ------------------------------------------------------

NET LOSS                                                         $ (48,685,000)           $  (211,000)       $ (1,536,000)
                                                                   ======================================================

NET LOSS PER COMMON SHARE                                        $       (6.01)           $      (.03)       $       (.19)
                                                                   ======================================================
</TABLE>

See Notes to Consolidated Financial Statements.


                                       39
<PAGE>
AMERICAN PACIFIC CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED SEPTEMBER 30, 1997, 1996 AND 1995

<TABLE>
<CAPTION>

                                                                               1997                1996                1995
                                                                         -----------------------------------------------------------

CASH FLOWS FROM OPERATING ACTIVITIES:
<S>                                                                      <C>                   <C>                <C>          
   Net loss                                                              $(48,685,000)         $  (211,000)       $ (1,536,000)
                                                                         --------------------------------------------------------
   Adjustments to reconcile net loss to net cash provided by operating
   activities:
     Depreciation and amortization                                          7,685,000            7,810,000           5,883,000
     Fixed asset impairment charge                                         52,605,000
     Employee separation and management reorganization costs                3,616,000
     Basis in development property sold                                     1,498,000            2,449,000           1,614,000
     Development property additions                                          (229,000)            (784,000)           (384,000)
     Equity in real estate venture                                           (200,000)            (700,000)
     Cash received on equity interest estate venture                          200,000              700,000
     Changes in assets and liabilities:
       Decrease in short-term investments                                   2,000,000
       (Increase) decrease in accounts and notes receivable                (1,286,000)          (1,480,000)          5,525,000
       (Increase) decrease in income tax receivable                                              2,570,000          (2,570,000)
       (Increase) decrease in inventories                                     181,000           (4,203,000)         (1,411,000)
       (Increase) decrease in restricted cash                               1,389,000           (1,226,000)         (2,159,000)
       (Increase) decrease in prepaid expenses and other                       32,000              198,000            (133,000)
       Increase (decrease) in accounts payable and accrued liabilities        870,000             (265,000)            (17,000)
       Increase (decrease) in deferred income taxes                       (10,101,000)            (467,000)          5,170,000
                                                                          ----------------------------------------------------
       Total adjustments                                                   58,260,000           4,602,000           11,518,000
                                                                          ----------------------------------------------------
         Net cash provided by operating activities                          9,575,000           4,391,000            9,982,000
                                                                          ----------------------------------------------------
CASH FLOWS FROM INVESTING ACTIVITIES:
   Capital expenditures                                                    (1,557,000)          (3,248,000)         (4,462,000)
   Real estate equity advances                                             (2,680,000)          (2,946,000)         (3,199,000)
                                                                          ----------------------------------------------------
   Return of capital on real estate equity advances                         1,130,000            1,973,000
         Net cash used for investing activities                            (3,107,000)          (4,221,000)         (7,661,000)
                                                                          ----------------------------------------------------
CASH FLOWS FROM FINANCING ACTIVITIES:
   Principal payments on debt                                              (6,168,000)          (6,166,000)
   Issuance of common stock                                                   236,000               47,000              82,000
   Treasury stock acquired                                                   (156,000)             (90,000)           (747,000)
                                                                          ----------------------------------------------------
         Net cash used for financing activities                            (6,088,000)          (6,209,000)           (665,000)
                                                                          ----------------------------------------------------
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS                          380,000           (6,039,000)          1,656,000
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD                             18,501,000           24,540,000          22,884,000
                                                                          ----------------------------------------------------
CASH AND CASH EQUIVALENTS, END OF PERIOD                                  $18,881,000          $18,501,000        $ 24,540,000
                                                                          ====================================================
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during period for interest (net of amounts capitalized)         $ 1,427,000          $ 2,197,000        $  1,700,000
                                                                          ==========================================================

SUPPLEMENTAL SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Excess additional pension liability                                                            $ 1,175,000        $    606,000
                                                                      ==============================================================
</TABLE>

See Notes to Consolidated Financial Statements.


                                       40
<PAGE>
AMERICAN PACIFIC CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
FOR THE YEARS ENDED SEPTEMBER 30, 1997, 1996 AND  1995

<TABLE>
<CAPTION>

                                                                            Retained                      Note            Excess
                                  Number of    Par Value of  Capital in     Earnings                      Receivable      Additional
                                  Common       Shares        excess of      (Accumulated      Treasury    from the Sale   Pension
                          Notes   Shares       Issued        Par Value      Deficit)          Stock       of Stock        Liability
                         -----------------------------------------------------------------------------------------------------------

<S>                              <C>            <C>           <C>             <C>             <C>             <C>
BALANCES,                        8,190,691      $820,000      $78,205,000      $17,725,000      $(42,000)     $(97,000)    (765,000)
   OCTOBER 1, 1994                                                              (1,536,000)
Net loss
Issuance of common
 stock                      11      21,400         2,000           80,000
Treasury stock acquired           (111,300)                                                      (747,000)
Excess additional
 pension liability           8                                                                                              606,000
                                ----------------------------------------------------------------------------------------------------
BALANCES,                        8,100,791       822,000       78,285,000       16,189,000       (789,000)     (97,000)    (159,000)
   SEPTEMBER 30, 1995                                                             (211,000)
Net loss
Issuance of common stock    11      12,000         1,000           46,000

Treasury stock acquired            (14,170)                                                       (90,000)
Excess additional
 pension liability           8                                                                                              159,000
                                 ---------------------------------------------------------------------------------------------------
BALANCES,
   SEPTEMBER 30, 1996            8,098,621       823,000       78,331,000       15,978,000       (879,000)     (97,000)
                                 ---------------------------------------------------------------------------------------------------
Net loss                                                                       (48,685,000)
Issuance of common stock
                            11      61,000         6,000          230,000
Treasury stock acquired            (22,084)                                                      (156,000)
                                ----------------------------------------------------------------------------------------------------
BALANCES,
   SEPTEMBER 30, 1997            8,137,537      $829,000      $78,561,000     $(32,707,000)   $(1,035,000)    $(97,000)
                                ====================================================================================================
</TABLE>

See Notes to Consolidated Financial Statements.




                                       41


<PAGE>
AMERICAN PACIFIC CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED SEPTEMBER 30, 1997, 1996 AND 1995


1.      SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

        PRINCIPLES OF  CONSOLIDATION  - The  consolidated  financial  statements
        include the accounts of American  Pacific  Corporation and  Subsidiaries
        (the "Company").  All significant intercompany accounts and transactions
        have been eliminated.

        CASH AND CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS - All highly liquid
        investment  securities  with a  maturity  of three  months  or less when
        acquired are considered to be cash equivalents.  Short-term  investments
        consist of investment securities with maturities, when acquired, greater
        than three months but less than one year. The Company adopted  Statement
        of Financial  Accounting  Standards  ("SFAS") No. 115,  "Accounting  for
        Certain  Investments in Debt and Equity Securities," during fiscal 1995.
        In accordance with SFAS No. 115, prior year's financial  statements have
        not been restated to reflect the change in accounting method.  There was
        no cumulative effect as a result of adopting SFAS No. 115 in 1995.

        The Company's  investment  securities,  along with certain cash and cash
        equivalents  that are not  deemed  securities  under SFAS No.  115,  are
        carried  on the  consolidated  balance  sheets  in  the  cash  and  cash
        equivalents and short-term investments categories. SFAS No. 115 requires
        all securities to be classified as either  held-to-maturity,  trading or
        available-for-sale. Management determines the appropriate classification
        of its  investment  securities at the time of purchase and  re-evaluates
        such determination at each balance sheet date.  Pursuant to the criteria
        that are  prescribed  by SFAS No. 115,  the Company has  classified  its
        investment   securities   as   available-for-sale.    Available-for-sale
        securities  are  required  to be carried at fair  value,  with  material
        unrealized  gains  and  losses,  net  of  tax,  reported  in a  separate
        component of shareholders'  equity.  Realized gains and losses are taken
        into income in the period of  realization.  The estimated  fair value of
        the Company's  portfolio of investment  securities at September 30, 1997
        and 1996 closely  approximated  amortized  cost.  There were no material
        unrealized  gains or losses on  investment  securities  and no  recorded
        adjustments to amortized cost at September 30, 1997 or 1996.

        RELATED  PARTY  NOTES   RECEIVABLE  -  Related  party  notes  receivable
        represent  demand notes bearing interest at a bank's prime rate from the
        Chairman and two officers of the Company.

        INVENTORIES  -  Inventories  are  stated at the lower of cost or market.
        Cost  of the  specialty  chemicals  segment  inventories  is  determined
        principally  on a moving  average  basis  and cost of the  environmental
        protection  equipment segment  inventories is determined  principally on
        the specific identification basis.

        PROPERTY,  PLANT AND  EQUIPMENT  -  Property,  plant and  equipment  are
        carried at cost less accumulated depreciation.  The Company periodically
        assesses  the  recoverability  of  property,  plant  and  equipment  and
        evaluates  such  assets  for  impairment  whenever  events or changes in
        circumstances  indicate that the carrying  amount of an asset may not be
        recoverable. Asset impairment is determined to exist if estimated future
        cash

                                                     42
<PAGE>
        flows,  undiscounted  and without  interest  charges,  are less than the
        carrying  amount.  Depreciation  is computed on the straight line method
        over the  estimated  productive  lives of the  assets (3 to 12 years for
        machinery and equipment and 15 to 31 years for buildings and









                                      42-A
<PAGE>

         improvements).  An impairment charge of $52,605,000 relating to certain
         specialty chemical assets was recognized in fiscal 1997. (See Note 13.)

        DEVELOPMENT  PROPERTY - Development  property consists of commercial and
        industrial  land  (principally   improved  land).  During  fiscal  1993,
        approximately 240 acres,  representing  $12,300,000 in carrying value of
        development property, was contributed to a real estate limited-liability
        company  (see Note 5).  Development  property  is carried at cost not in
        excess of estimated net realizable value. Estimated net realizable value
        is based upon the net sales proceeds anticipated in the normal course of
        business,  less  estimated  costs to complete or improve the property to
        the condition used in determining the estimated selling price, including
        future  interest and  property  taxes  through the point of  substantial
        completion.   Cost  includes  the  cost  of  land,   initial   planning,
        development  costs and carrying costs.  Carrying costs include  interest
        and property taxes until projects are substantially  complete.  Interest
        capitalized is the amount of interest on the Company's net investment in
        property under development limited to total interest expense incurred in
        a period. No interest was capitalized on development property during the
        three-year period ended September 30, 1997. Certain development property
        in Nevada is pledged to secure debt. (See Note 6.)

        DEBT ISSUE COSTS - Debt issue costs represent costs associated with debt
        and are amortized on the effective interest method over the terms of the
        related indebtedness.

        FAIR VALUE DISCLOSURE AS OF SEPTEMBER 30, 1997:

        Cash and cash  equivalents,  accounts and notes  receivable,  restricted
        cash, and accounts payable and accrued  liabilities - The carrying value
        of these items is a reasonable estimate of their fair value.

        Notes payable,  current  portion of long-term debt and warrants - Market
        quotations  are not available for any of the  Company's  notes  payable,
        long-term  debt or  warrants.  See  Note 6 for a  description  of  these
        instruments.  Approximately  $40 million of notes and  related  warrants
        were issued in February  1992.  The Company  believes that similar terms
        would be available at September 30, 1997.

        SALES AND REVENUE RECOGNITION - Sales of the specialty chemicals segment
        are  recognized  as the  product  is  shipped  and  billed  pursuant  to
        outstanding  purchase  orders.  Sales  of the  environmental  protection
        equipment  segment are recognized on the percentage of completion method
        for  long-term  contracts  and when the  product  is  shipped  for other
        contracts.  Profit from sales of development  property and the Company's
        equity in real estate equity  investments is recognized  when and to the
        extent permitted by SFAS No. 66, "Accounting for Sales of Real Estate".

        RESEARCH AND DEVELOPMENT - Research and development costs are charged to
        operations  as incurred.  These costs are for  proprietary  research and
        development  activities  that are expected to  contribute  to the future
        profitability of the Company.

        NET LOSS PER  COMMON  SHARE - Net loss per  common  share is  determined
        based on the  weighted  average  number  of  common  shares  outstanding
        (8,105,000,  8,104,000 and  8,177,000 for the years ended  September 30,
        1997, 1996 and 1995). Common share equivalents,  although not considered
        during net loss years, consist of outstanding stock


                                       43
<PAGE>
        options and  warrants.  See Note 6 for a  description  of the  potential
        effects on net income per common share of warrants  issued in connection
        with the issuance of certain notes.

        The  Company has adopted  the  disclosures-only  provision  of SFAS 123,
        "Accounting  for  Stock-Based  Compensation".  The  Company  applies APB
        Opinion No. 25 and related  interpretations  in accounting for its stock
        options.  Under APB 25, no compensation  cost has been recognized in the
        financial  statements for stock options granted.  The fair value of each
        option grant is  estimated on the date of grant using the  Black-Scholes
        option-pricing  model. Had compensation cost for the stock option grants
        been determined  based on the fair value at the date of grant for awards
        consistent  with the  provision of SFAS 123, the  Company's net loss per
        common  share  would  have  been  decreased  to the  pro  forma  amounts
        indicated below for the year ended September 30:

                                                                 1997

             Net loss-as reported                         $ (48,685,000)
             Net loss-pro forma                             (49,791,000)

             Net loss per common share-as reported        $       (6.01)
             Net loss per common share-pro forma                  (6.14)


        The fair value of each option  granted in fiscal year 1997 was estimated
        using the following  assumptions for the  Black-Scholes  options pricing
        model:  (i) no dividends;  (ii) expected  volatility of 55%,  (iii) risk
        free interest rates averaging 6.1% and (iv) the expected average life of
        3.3 years.  The weighted  average  fair value of the options  granted in
        1997 was $2.97.  Because the SFAS 123 method of accounting  has not been
        applied to options  granted prior to October 1, 1995,  the resulting pro
        forma net income may not be  representative  of that to be  expected  in
        future years.

        INCOME  TAXES  -  The  Company  accounts  for  income  taxes  under  the
        provisions of SFAS No. 109, "Accounting for Income Taxes".

        ESTIMATES AND ASSUMPTIONS - The  preparation of financial  statements in
        conformity  with  generally  accepted  accounting   principles  requires
        management to make  estimates and  assumptions  that affect the reported
        amounts of assets and  liabilities  and disclosure of contingent  assets
        and liabilities at the date of the financial statements and the reported
        amounts  of  revenues  and  expenses   during  the   reporting   period.
        Significant estimates used by the Company include estimated useful lives
        for  depreciable  and  amortizable   assets,  the  estimated   valuation
        allowance for deferred tax assets, and estimated cash flows in assessing
        the recoverability of long-lived assets.  Actual results may differ from
        estimates.

        RECENTLY  ISSUED  ACCOUNTING   STANDARDS  -  The  Financial   Accounting
        Standards  Board  ("FASB")  recently  issued SFAS No. 128  "Earnings per
        Share."  This   statement   establishes   standards  for  computing  and
        presenting earnings per share and is effective for financial  statements
        issued for periods ending after December 15, 1997.  Earlier  application
        of this statement is not permitted.  Upon adoption,  the Company will be
        required to restate (as applicable) all prior-period  earnings per share
        data  presented.  Management  believes that the  implementation  of this
        statement will not have a significant impact on earnings per share.


                                       44
<PAGE>
        In June 1997,  the FASB issued SFAS No.  130,  "Reporting  Comprehensive
        Income." This  statement  requires  companies to classify items of other
        comprehensive  income  by their  nature  in a  financial  statement  and
        display the accumulated balance of other comprehensive income separately
        from  retained  earnings and  additional  paid-in  capital in the equity
        section of a balance  sheet,  and is effective for financial  statements
        issued for fiscal years  beginning  after December 15, 1997.  Management
        does not  believe  this  statement  will  have  material  impact  on the
        Company's financial statements.

        The  FASB  issued  SFAS  No.  131,  "Disclosures  about  Segments  of an
        Enterprise and Related Information," which is effective for fiscal years
        beginning  after  December  15,  1997.  This  statement   redefines  how
        operating segments are determined and requires qualitative disclosure of
        certain   financial  and  descriptive   information  about  a  company's
        operating  segments.  The  Company  will  adopt SFAS No. 131 in the year
        ending September 30, 1999. Management has not yet completed its analysis
        of which  operating  segments  it will report on to comply with SFAS No.
        131.

        In  November   1996,   the  American   Institute  of  Certified   Public
        Accountants'  Accounting  Standards Executive Committee issued Statement
        of Position ("SOP") 96-1, "Environmental  Remediation Liabilities." This
        SOP  provides  guidance  on  accounting  for  environmental  remediation
        liabilities.  This SOP discusses when an environmental  liability should
        be  recognized  in the  financial  statements  and provides  guidance in
        measuring the liability by discussing  the types of costs to be included
        in the liability. This SOP is effective for fiscal years beginning after
        December 15, 1996.  Management does not believe that the  implementation
        of this SOP in fiscal 1998 will have a material  impact on the Company's
        financial statements.

        RECLASSIFICATION - Certain  reclassifications have been made in the 1996
        and 1995  consolidated  financial  statements in order to conform to the
        presentation used in 1997.

2.      INVENTORIES

        Inventories consist of the following:

                                                 -------------------------------
                                                            September 30,
                                                 -------------------------------
                                                         1997          1996
                                                         ----          ----

        Work-in-process                          $ 3,349,000        $  5,011,000
        Raw material and supplies                  7,767,000           6,286,000
                                                 -------------------------------

        Total                                    $11,116,000        $ 11,297,000
                                                 ===============================

3.      RESTRICTED CASH

        At September 30, 1997,  restricted cash consists, in part, of $1,160,000
        held in a cash  collateral  account by Seafirst  Bank,  the lender which
        provided a term loan (the "AP Facility Loan") as the principal financing
        for an ammonium  perchlorate ("AP")  manufacturing  facility erected and
        operated  by the  Company.  Funds in the  cash  collateral  account  are
        restricted  for future  indemnity  payments (if any)  relating to the AP
        Facility  Loan.  The AP Facility Loan was repaid in 1994. The $1,160,000
        will be retained in the cash  collateral  account until May 11, 1999, at
        which time the balance remaining after indemnity  payments (if any) will
        be returned to Thiokol Corporation ("Thiokol"). The

                                       45
<PAGE>
        Company's  obligation to return such funds is included in long-term debt
        at September 30, 1997. Any indemnity  payments made will serve to reduce
        the cash collateral account and the Company's obligation to Thiokol.

        Restricted cash at September 30, 1997 also includes $2,420,000 held in a
        trust account by the Trustee under the indenture relating to $40,000,000
        of notes (the "Azide  Notes") sold in a financing  concluded in February
        1992. (See Note 6.)

















                                      45-A
<PAGE>
4.      PROPERTY, PLANT AND EQUIPMENT

        Property, plant and equipment are summarized as follows:

                                          --------------------------------------
                                                    September 30,
                                          --------------------------------------
                                            1997                    1996
                                            ----                    ----

    Land                                $   309,000              $   305,000
    Buildings and improvements            1,753,000               13,865,000
    Machinery and equipment              20,759,000               76,935,000
    Construction in progress                380,000                  139,000
                                        ----------------------------------------
    Total                                23,201,000               91,244,000
    Less:  accumulated depreciation       3,887,000               14,027,000
                                        ----------------------------------------

    Property, plant and equipment, net  $19,314,000              $77,217,000
                                        ========================================

        In 1995,  approximately $1,800,000 in interest costs were capitalized on
        assets  constructed for the Company's own use.  Certain of the Company's
        property,  plant and  equipment is pledged as collateral to secure debt.
        (See Note 6.) A fixed asset  impairment  charge was  recognized in 1997.
        (See Note 13.)

5.      REAL ESTATE EQUITY INVESTMENTS

        During fiscal 1993, the Company  contributed  approximately 240 acres of
        development   property  to  Gibson  Ranch  Limited   Liability   Company
        ("GRLLC").  The development property contributed had a carrying value of
        approximately  $12,300,000  at  the  date  of  contribution,  which  was
        transferred  to  Real  Estate  Equity  Investments  on the  accompanying
        consolidated balance sheets. The Company's interest in GRLLC is assigned
        to  secure  the Azide  Notes.  A local  real  estate  development  group
        ("Developer")  contributed an adjacent 80-acre parcel to GRLLC. GRLLC is
        developing the 320-acre parcel  principally as a residential real estate
        development.

        Each of The Company and Developer is obligated to loan to GRLLC, under a
        revolving line of credit, up to $2,400,000 at an annual interest rate of
        10 percent.  However,  Developer  will not be required to advance  funds
        under  its  revolving  line  of  credit  until  the  Company's  line  is
        exhausted.  At September  30, 1996,  the Company had advanced all of its
        committed  amount  under this  line.  In  November,  1995,  the  Company
        committed to advance an additional $1,700,000 to Developer. Developer is
        required to advance any funds  received to GRLLC.  Funds  advanced under
        this additional  commitment  bear annual  interest of 12 percent.  Total
        advances  under these  commitments  were  $3,171,000  and  $2,828,000 at
        September 30, 1997 and 1996.

        Developer is the  managing  member of GRLLC and is managing the business
        conducted by GRLLC. Certain major decisions,  such as incurring debt and
        changes  in the  development  plan  or  budget  may be  made  only  by a
        management  committee on which the Company is equally  represented.  The
        profits  and losses of GRLLC will be split  equally  between the Company
        and  Developer  after the return of advances  and agreed upon values for
        initial contributions.




                                       46
<PAGE>
        GRLLC operates on a calendar  year. The Company  recognizes its share of
        the equity in GRLLC on a current quarterly basis.  Summarized  financial
        information  for GRLLC as of and for the years ended  December  31, 1996
        and 1995 and as of and for the  nine-month  period ended  September  30,
        1997 was as follows:

                            September 30,  December 31,      December 31,
                              1997              1996             1995
                            -------------  -----------       -------------

Income Statement:
   Revenues                $13,776,000      $18,602,000       $ 2,712,000
   Gross Profit              1,557,000        3,983,000           560,000
   Operating Expenses          829,000        1,555,000           875,000
   Net Income              $   733,000      $ 2,428,000       $  (315,000)

Balance Sheet:
   Assets                  $26,840,000      $23,233,000       $22,554,000
   Liabilities              12,273,000        9,554,000         9,205,000
   Equity                  $14,568,000      $13,679,000       $13,349,000


         GRLLC's balance sheet is not classified.  Assets consist principally of
         inventories and liabilities  consist  principally of Notes and accounts
         payable.  Inventories were $24,308,000,  $21,659,000 and $21,738,000 at
         September   30,  1997,   December  31,  1996  and  December  31,  1995,
         respectively.

        In July 1990, the Company  contributed  $725,000 to Gibson Business Park
        Associates  1986-I, a real estate development  limited  partnership (the
        "Partnership"),  in return for a 70%  interest  as a general and limited
        partner, and other limited partners contributed $315,000 in return for a
        30% interest as limited  partners.  Such other limited partners included
        the Company's Chairman and a former Executive Vice-President and certain
        members of the Company's Board of Directors.  The Partnership,  in turn,
        contributed   $1,040,000  to  3770  Hughes  Parkway  Associates  Limited
        Partnership,  a Nevada limited partnership ("Hughes Parkway"), in return
        for a 33% interest as a limited partner in Hughes  Parkway.  The Company
        entered  into an  agreement  with Hughes  Parkway  pursuant to which the
        Company leases office space in a building in Las Vegas, Nevada (see Note
        10).

6.      NOTES PAYABLE AND LONG-TERM DEBT

        Notes payable and long-term debt,  collateralized by property, plant and
        equipment used in the production of sodium azide, and  collateralized by
        substantially   all   development   property  and  real  estate   equity
        investments of the Company, is summarized as follows:
<TABLE>
<CAPTION>

                                                   -----------------------------------------------------
                                                                     September 30,
                                                   -----------------------------------------------------
                                                            1997                          1996
                                                            ----                          ----

       Subordinated secured term notes
       <S>                                         <C>                            <C>
       (interest at 11%)                           $     28,740,000               $      33,310,000
       Obligation to deliver AP (see Note 9)              1,166,000                       2,334,000
       Indemnity obligation (see Notes 3 and 9)           1,160,000                       1,142,000
                                                   --------------------------------------------------------
       Total                                             31,066,000                      36,786,000
       Less current portion                               6,166,000                       7,334,000
                                                   --------------------------------------------------------

       Total                                       $     24,900,000               $      29,452,000
                                                   ========================================================
</TABLE>


                                       47
<PAGE>

         In February 1992, the Company concluded the issuance of the Azide Notes
         financing for the design,  construction  and start-up of a sodium azide
         facility.  The funds were  provided  by a major state  public  employee
         retirement  fund  and a  leading  investment  management  company.  The
         financing  was  in  the  form  of  $40,000,000   principal   amount  of
         noncallable subordinated secured notes issued at par, providing for the
         semi-annual  payment  in  arrears  of  interest  at the rate of 11% per
         annum. Principal is to be amortized to the extent of $5,000,000 on each
         of the fourth (February 1996) through ninth (February 2001) anniversary
         dates of the funding,  with the remaining  $10,000,000 principal amount
         to be repaid on the tenth anniversary date. The Azide Notes are secured
         by the fixed assets and stock of American Azide Corporation ("AAC"), an
         indirect  wholly-owned  subsidiary  of the  Company,  as  well  as by a
         mortgage on land in Clark County, Nevada being developed by the Company
         and by certain restricted cash (see Note 3). Approximately 240 acres of
         such land has been contributed to GRLLC subject to certain  conditions.
         The Company's interest in GRLLC has been assigned to secure the Azide


















                                      47-A


<PAGE>
        Notes (see Note 5). The Company  issued to the  purchasers  of the Notes
        warrants (the "Warrants"),  exercisable for a ten-year period commencing
        on December 31, 1993, to purchase  shares of Common Stock at an exercise
        price of $14.00 per share. The maximum number of shares purchasable upon
        exercise  of  the  Warrants  is  2,857,000  shares.   The  Warrants  are
        exercisable,  at the  option  of their  holders,  to  purchase  up to 20
        percent of the common  stock of AAC,  rather than the  Company's  Common
        Stock.  In the  event of such an  election,  the  exercise  price of the
        Warrants will be based upon a pro rata share of AAC's capital,  adjusted
        for earnings and losses, plus interest from the date of contribution. At
        the option of the Warrant  holders,  the exercise  price of the Warrants
        may be paid by delivering an equal amount of Azide Notes.

        The indenture  imposes various  operating  restrictions upon the Company
        including   restrictions  on  (i)  the  incurrence  of  debt;  (ii)  the
        declaration of dividends and the purchase and repurchase of stock; (iii)
        certain  mergers and  consolidations,  and (iv) certain  dispositions of
        assets.   Management  believes  the  Company  has  complied  with  these
        operating restrictions.

         On each of December  31, 1995,  1997 and 1999,  holders of the Warrants
         have or will have the right to put to the Company as much as  one-third
         thereof based upon the differences  between the Warrant  exercise price
         and prices  determined  by  multiplying  the  Company's  fully  diluted
         earnings per share at multiples of 13, 12 and 11, respectively, but the
         Company's  obligation  in such respect is limited to $5,000,000 on each
         of such dates and to $15,000,000 in the aggregate.  Such put rights may
         not be  exercised  if the  Company's  Common Stock has traded at values
         during the  preceding  90-day  period  that would  yield to the warrant
         holders a 25% internal rate of return to the date of the put (inclusive
         of the 11% Azide  Notes'  yield).  At  September  30,  1997,  it is not
         probable  that the  remaining  put rights will be  exercised  since the
         Company  believes,  based on current market  conditions, that its stock
         will trade at a higher  multiple of fully  diluted  earnings  per share
         than the 11  multiple  used to  determine  the put  value,  if any,  at
         December  31,  1999,  thereby  making  exercise  of the  Warrants  more
         valuable to the holders thereof than exercise of the put rights.  On or
         after  December 31 of each of the years 1995 through 1999,  the Company
         may  call  up to 10% of the  Warrants  (but  no  more  than  50% in the
         aggregate)  at prices that would  provide a 30% internal rate of return
         to the holders  thereof  through the date of call (inclusive of the 11%
         Azide Notes' yield).  The holders of the Warrants were also granted the
         right to require  that the Common  Stock  underlying  the  Warrants  be
         registered on one occasion, as well as certain incidental  registration
         rights.

        The Company has accounted  for the proceeds of the financing  applicable
        to the Warrants (and the potential put right) as temporary capital.  Any
        adjustment  of the  value  assigned  at the  date  of  issuance  will be
        reported as an adjustment to retained  earnings.  The value  assigned to
        the Warrants was  determined in  accordance  with  Accounting  Principle
        Board Opinion No. 14 "Accounting  for  Convertible  Debt and Debt Issued
        with Stock Purchase Warrants" and was based upon the relative fair value
        of the Warrants and  indebtedness at the time of issuance.  Although not
        applicable for the fiscal years ended September 30, 1997, 1996 and 1995,
        net income per common share will be calculated on an "equity" basis or a
        "debt" basis using the more  dilutive of the two  methods.  The "equity"
        basis  assumes the Warrants  will be exercised and the effect of the put
        feature adjustment, if any, on earnings available to common shareholders
        will  be  reversed.  The  treasury  stock  method  will  then be used to
        calculate  net  additional  shares.  The "debt"  basis  assumes that any
        remaining  puts will be exercised (if the rights are  available) and the
        Warrants will not be considered common stock equivalents.

                                       48

<PAGE>
        Notes payable and long-term debt maturities are as follows:

---------------------------------------
       For the Years Ending
         September 30,
---------------------------------------


              1998                                     $ 6,166,000
              1999                                       6,160,000
              2000                                       5,000,000
              2001                                       5,000,000
              2002                                       8,740,000
                                                       -----------
              Total                                    $31,066,000
                                                       ===========

7.      INCOME TAXES

         The Company  accounts  for income  taxes using the asset and  liability
         approach  required  by SFAS  109.  The  asset  and  liability  approach
         requires the recognition of deferred tax liabilities and assets for the
         expected future tax consequences of temporary  differences  between the
         carrying  amounts  and  the  tax  bases  of the  Company's  assets  and
         liabilities.  Future tax benefits attributable to temporary differences
         are recognized to the extent that realization of such benefits are more
         likely than not.  These  future tax  benefits  are measured by applying
         currently enacted tax rates.

         The following  table  provides an analysis of the Company's  credit for
         income taxes for the years ended September 30:

<TABLE>
<CAPTION>

                                                        1997                  1996              1995
                                                  ------------------    --------------     --------------
<S>                                                 <C>                                                 
          Current                                   $                    $(1,349,000)       $(4,888,000)

          Deferred (federal and state)               (10,101,000)          1,240,000          4,097,000
                                                  ------------------    --------------     --------------

          Credit for income taxes                   $(10,101,000)        $  (109,000)       $  (791,000)
                                                  ==================    ==============     ==============
</TABLE>

        A valuation  allowance for the deferred tax asset was established in the
        amount of $10,431,000 in 1997. The valuation  allowance is necessary due
        to the uncertainty  related to the realizability of future tax benefits.
        The deferred tax assets are composed,  for the most part, of alternative
        minimum tax credits and net operating  losses.  The alternative  minimum
        tax credit  carryforward,  valued at  approximately  $1,233,000,  may be
        carried  forward  indefinitely  as a credit against regular tax. The net
        operating loss carryforwards,  valued at approximately $16,278,000, will
        begin to expire for tax purposes in 2008 as follows:
<TABLE>
<CAPTION>

                                                       NOL DEDUCTION                     Tax Rate             NOL Asset
                                                      --------------                   -----------          -------------
          Expiration of net operating losses
<S>            <C>                                     <C>                                 <C>               <C>
               2008                                    $ 3,398,000                         34.0%             $1,155,000
               2009                                     25,607,000                         34.0%              8,706,000
               2010                                     14,080,000                         34.0%              4,787,000
               2011 and thereafter                       4,791,000                         34.0%              1,630,000
                                                      ------------                                          ------------

                       TOTAL                           $47,876,000                                           $16,278,000
                                                      ============                                          ============
</TABLE>



                                       49
<PAGE>
        The   Company's   effective   tax  rate   declined  to  16.7%  with  the
        establishment of the valuation  allowance.  The Company's  effective tax
        rate will be 0% until the net operating losses expire or the Company has
        taxable  income  necessary  to  eliminate  the  need  for the  valuation
        allowance. The credit for income taxes for the years ended September 30,
        1997,  1996 and 1995,  differs  from the amount  computed at the federal
        income tax statutory rate as a result of the following:

<TABLE>
<CAPTION>

                                                       1997            %            1996            %            1995            %
                                               -------------------------------------------------------------------------------------
<S>                                                <C>                <C>        <C>               <C>       <C>              <C>  
          Expected credit for income taxes         $(20,591,000)      34.0%      $ (109,000)       34.0%     $  (814,000)     35.0%
          Adjustment:
             Nondeductible expenses                      59,000       (0.1%)
             Surtax benefit                                                                                       23,000      (1.0%)
             Tax credit limitation due to the
             valuation allowance                     10,431,000      (17.2%)
                                               ----------------              ---------------------        --------------

          Credit for income taxes                  $(10,101,000)      16.7%      $ (109,000)       34.0%     $  (791,000)     34.0%
                                               ================              =====================        ==============
</TABLE>

        The components of the net deferred taxes at September 30, 1997, 1996 and
1995 consisted of the following:

<TABLE>
<CAPTION>

          DEFERRED TAX ASSETS:
          Non-current:
<S>                                                        <C>                  <C>                 <C>        
               Net operating losses                        $16,278,000          $16,618,000         $14,353,000
               Alternative minimum tax credits               1,233,000            1,395,000           1,354,000
               Employee separation and management
                reorganization costs                         1,172,000
               Inventory capitalization                        436,000              349,000             269,000
               Accruals                                        408,000              127,000
               Other                                           250,000
                                                           -----------          -----------         -----------
          Total deferred tax assets:                       $19,777,000          $18,489,000         $15,976,000
                                                           -----------          ------------        -----------
          DEFERRED TAX LIABILITIES:
          Non-current:
               Property (includes azide impairment
                in 1997)                                   $(4,350,000)        $(23,711,000)       $  (25,394,000)
               Accrued income and expenses                    (653,000)            (412,000)             (569,000)
               State Taxes                                    (600,000)            (600,000)             (575,000)
               Other taxes payable                          (1,251,000)          (1,945,000)                 --
               Amortization                                 (1,020,000)            (737,000)                 --
               Other                                        (1,472,000)          (1,185,000)               (6,000)
                                                           -----------          ------------          -------------
          Total deferred tax liabilities:                   (9,346,000)         (28,590,000)          (26,544,000)
                                                           -----------          ------------          -------------
          Preliminary net deferred tax asset                10,431,000          (10,101,000)          (10,568,000)
          Valuation allowance for deferred tax asset       (10,431,000)
                                                           ------------         ------------          -------------
          Net deferred tax credit:                         $         0         $(10,101,000)         $(10,568,000)
                                                           ============         ============          =============
</TABLE>


                                       50
<PAGE>
8.       EMPLOYEE BENEFIT PLANS

         The Company maintains, for the benefit of its employees, a group health
         and life benefit plan, an employee  stock  ownership plan ("ESOP") that
         includes a Section 401(k) feature,










                                      50-A
<PAGE>
        and a defined  benefit  pension  plan  (the  "Plan").  The ESOP  permits
        employees to make  contributions.  The Company does not presently  match
        any portion of employee ESOP contributions.

        All  full-time  employees  age 21 and over with one year of service  are
        eligible  to  participate  in the Plan.  Benefits  are paid  based on an
        average of earnings,  retirement age, and length of service, among other
        factors.

        The discount rate was 7.5% in 1997 and 1996 and 7% in 1995.  The rate of
        salary  progression used to determine the projected benefit  obligations
        was 5% in 1997, 1996 and 1995. The expected  long-term rate of return on
        plan assets was 8% in 1997 and 1996 and 7% in 1995. The following  table
        reconciles the Plan's funded status and summarizes amounts recognized in
        the  Company's  consolidated  financial  statements  for the years ended
        September 30, 1997 and 1996.

<TABLE>
<CAPTION>

                                                                       -----------------------------------------------------
                                                                           1997                      1996
                                                                       -----------------------------------------------------
        Actuarial present value of benefit obligations:
<S>                                                                    <C>                    <C>           
        Vested benefits                                                $ 7,758,000            $    6,524,000
        Nonvested benefits                                               1,219,000                 1,254,000
                                                                       -----------------------------------------------------
        Accumulated benefit                                            $ 8,977,000            $    7,778,000
                                                                       =====================================================
        Projected benefit obligation                                   $11,275,000            $    9,754,000
        Plan assets at fair value                                        9,937,000                 8,459,000
                                                                       -----------------------------------------------------
        Projected benefit obligation in excess of
         Plan assets                                                     1,338,000                 1,295,000
        Unrecognized net transition obligation
         amortized over fifteen years                                     (764,000)                 (916,000)
        Unrecognized net loss and prior service cost                      (174,000)                 (499,000)
                                                                       -----------------------------------------------------
        Accrued (Prepaid) pension                                      $   400,000            $     (120,000)
                                                                       =====================================================
</TABLE>

        Net  periodic  pension cost was  $986,000,  $1,187,000  and  $1,295,000,
        respectively, for the years ended September 30, 1997, 1996 and 1995, and
        consists of the following:
<TABLE>
<CAPTION>

                                                  ----------------------------------------------------------------------------
                                                               1997                    1996                  1995
                                                  ----------------------------------------------------------------------------
<S>                                                   <C>                     <C>                      <C>            
        Service cost                                  $       687,000         $       765,000          $       787,000
        Interest cost                                         772,000                 696,000                  620,000
        Return on Plan assets                              (1,415,000)               (519,000)                (708,000)
        Net total of other components                         942,000                 245,000                  596,000
                                                  ----------------------------------------------------------------------------

        Net periodic pension cost                     $       986,000         $     1,187,000          $     1,295,000
                                                  ============================================================================
</TABLE>

         See Note 16 for a discussion of the Company's  Supplemental  Retirement
         Plan.

9.      AGREEMENTS WITH THIOKOL CORPORATION

        In 1989,  the Company  entered into an Advance  Agreement  and Surcharge
        Agreement and certain other agreements  (collectively  the "NASA/Thiokol
        Agreements")  with Thiokol.  Under the Advance and Surcharge  Agreements
        Thiokol  was  required  to place  sufficient  orders  for AP such  that,
        combined with orders from other AP customers, the Company


                                       51
<PAGE>
         would  receive  revenues  in respect of at least 20 million  pounds per
         year,  5 million per quarter,  over seven years (140 million  pounds in
         the  aggregate),  beginning  with initial  production.  The Company was
         required  to  impose  a  surcharge  on all  sales of AP  sufficient  to
         amortize the AP Facility Loan over or during the period of such revenue
         assurance.

         On May 10, 1994,  the Company and Thiokol  executed an amendment to the
         Advance  Agreement  (the  "Amendment")  and the AP  Facility  Loan  was
         repaid.  Upon early  repayment  in full of the AP  Facility  Loan,  the
         Amendment  provided for the  termination  as fulfilled of the Surcharge
         Agreement and termination of certain other  agreements  relating to the
         repayment of advances (the Working Capital  Agreement and the Repayment
         Plan).

         The Amendment  provided for the Company to receive revenues,  excluding
         surcharge revenues,  from sales of AP of approximately $33 million, $28
         million and $20 million  during the fiscal years ending  September  30,
         1994, 1995 and 1996,  respectively.  Prior to the effective date of the
         Amendment,  the  Company  was  indebted  to Thiokol  for  approximately
         $10,208,000 under the Working Capital Agreement and Repayment Plan. The
         Amendment  required the Company to pay $750,000 of this amount  ratably
         as  deliveries  of AP were made over the  remainder  of the fiscal year
         ended  September 30, 1994. The remaining  obligation  under the Working
         Capital  Agreement and Repayment  Plan has been and will continue to be
         repaid by the Company through delivery of AP.


10.     COMMITMENTS AND CONTINGENCIES

        In fiscal  1993,  three  shareholder  lawsuits  were filed in the United
        States District Court for the District of Nevada against the Company and
        certain of its directors and officers  (the "Company  Defendants").  The
        complaints,  which were consolidated,  alleged that the Company's public
        statements  violated Federal securities laws by inadequately  disclosing
        information  concerning  its  agreements  with Thiokol and the Company's
        operations.  On November 27, 1995,  the U.S.  District  Court granted in
        part the Company's motion for summary judgment,  ruling that the Company
        had not violated the Federal  securities laws in relation to disclosures
        concerning the Company's  agreements with Thiokol. The remaining claims,
        which  related  to  allegedly   misleading  or  inadequate   disclosures
        regarding  Halotron,  were the  subject  of a jury  trial  that ended on
        January 17, 1996. The jury reached a unanimous  verdict that none of the
        Company  Defendants made misleading or inadequate  statements  regarding
        Halotron. The District Court thereafter entered judgment in favor of the
        Company Defendants on the Halotron claims.  The plaintiffs  appealed the
        summary  judgment  ruling and the  judgment  on the jury  verdict to the
        Ninth Circuit of the United States District Court of Appeals. On June 5,
        1997,  the Court of Appeals  affirmed the judgments of the United States
        District Court in favor of the Company Defendants. On June 19, 1997, the
        plaintiffs filed an Appellants  Petition for Rehearing and Suggestion of
        Rehearing En Banc with the Court of Appeals.  On September 3, 1997,  the
        Court of Appeals denied the Petition for Rehearing. In October 1997, the
        plaintiffs  filed a Petition  for Writ of  Certiorari  with the  Supreme
        Court of the United States.

        During the third  quarter of fiscal 1996,  the Company  settled  certain
        matters  with its  insurance  carrier  relating  to legal fees and other
        costs associated with the successful

                                       52
<PAGE>
        defense of the shareholder lawsuits. Under this settlement,  the Company
        was reimbursed for  approximately  $450,000 in costs that had previously
        been expensed and incurred in connection  with the defense.  Such amount
        was recognized as a reduction in operating expenses in the third quarter
        of fiscal 1996.  The insurance  carrier agreed to and has paid attorneys
        fees and other  defense costs  related to the  plaintiffs'  unsuccessful
        appeals referred to above.

        The  Company  was served  with a  complaint  on  December  10, 1993 in a
        lawsuit brought by limited partners in a partnership of which one of the
        Company's former subsidiaries,  divested in 1985, was a general partner.
        The plaintiffs alleged that the Company was liable to them in the amount
        of approximately $5.9 million, plus interest, on a guarantee executed in
        1982. In August 1996, the Company's  cross-motion  for summary  judgment
        was  granted by the  Superior  Court of the State of Delaware in and for
        New Castle County. The plaintiffs filed an appeal with the Supreme Court
        of the State of Delaware in January 1997. In October 1997,  the Delaware
        Supreme Court affirmed the Superior Court's judgment.

        Trace amounts of perchlorate chemicals were recently found in Lake Mead.
        Clark County,  Nevada,  where Lake Mead is situated,  is the location of
        Kerr-McGee Chemical Corporation's  ("Kerr-McGee") AP operations, and was
        the location of the Company's AP operations  until May 1988. The Company
        is cooperating  with State and local  agencies,  and with Kerr-McGee and
        other  interested  firms,  in the  investigation  and  evaluation of the
        source  or  sources  of  these  trace  amounts,  possible  environmental
        impacts, and potential  remediation methods.  Until these investigations
        and evaluations  have reached  appropriate  conclusions,  it will not be
        possible  for the Company to determine  the extent to which,  if at all,
        the Company may be called  upon to  contribute  to or assist with future
        remediation   efforts,  or  the  financial  impacts,  if  any,  of  such
        contributions  or  assistance.  Accordingly,  no accrual  for  potential
        losses  has  been  made  in  the  accompanying   Consolidated  Financial
        Statements of the Company.

        The Company is a party to an agreement with Utah Power and Light Company
        for its electrical  requirements.  The agreement provides for the supply
        of power for a minimum of a ten-year  period,  which began in 1988,  and
        obligates  the  Company to  purchase  minimum  amounts  of power,  while
        assuring the Company  competitive  pricing for its electricity needs for
        the duration of the  agreement.  Under the terms of the  agreement,  the
        Company's  minimum monthly charge for firm and  interruptible  demand is
        approximately $22,000.

        See Note 14 for a discussion of certain litigation involving Halotron.

        The Company and its  subsidiaries  are also involved in other  lawsuits.
        The Company  believes that these other lawsuits,  individually or in the
        aggregate, will not have a material adverse effect on the Company or any
        of its subsidiaries.

        As  discussed  in Note 5, the Company  entered  into an  agreement  with
        Hughes Parkway  pursuant to which the Company  leases office space.  The
        lease is for an initial  term of 10 years and is  subject to  escalation
        every three  years based on changes in the  consumer  price  index,  and
        provides for the Company to occupy 22,262 square feet of office space.


                                       53
<PAGE>
        Rent expense was  approximately  $550,000  during the fiscal years ended
        September 30, 1997, 1996 and 1995.  Future minimum rental payments under
        this lease for the years ending September 30, are as follows:

1998                                    550,000
1999                                    550,000
2000                                    275,000
                                     ----------
Total                                $1,375,000
                                     ==========











                                      53-A
<PAGE>
11.     SHAREHOLDERS' EQUITY

        The Company has authorized the issuance of 3,000,000 shares of preferred
        stock, of which 125,000 shares have been designated as Series A, 125,000
        shares  have been  designated  as Series B and 15,340  shares  have been
        designated  as Series C  redeemable  convertible  preferred  stock.  The
        Series C  redeemable  convertible  preferred  stock was  outstanding  at
        September  30,  1989,  was redeemed in December  1989,  and is no longer
        authorized for issuance. No preferred stock is issued or outstanding.

        The Company has granted  options and warrants to purchase  shares of the
        Company's  common stock at prices at or in excess of market value at the
        date of grant. The options and warrants were granted under various plans
        or by specific grants  approved by the Company's Board of Directors.  In
        1994,  the former  Executive  Vice  President  of the Company  exercised
        options for 45,000  shares of the  Company's  common  stock by executing
        demand  notes  bearing  interest  at a bank's  prime  rate for the total
        option price of $174,000.  Approximately  $97,000 of this amount remains
        outstanding at September 30, 1997. Interest income of $8,000, $7,000 and
        $8,000 was recorded on these notes in fiscal 1997, 1996 and 1995.

        Option and warrant transactions are summarized as follows:

                                    --------------------------------------------
                                    Shares Under
                                    Options and
                                      Warrants                 Option Price
                                    --------------------------------------------


October 1, 1994                         3,153,450           3.88  -    30.50
Granted                                   281,000           4.88  -     7.50
Exercised, expired or canceled           (104,400)          3.88  -    30.50
                                    --------------------------------------------
September 30, 1995                      3,330,050           3.88  -    21.50
Exercised, expired or canceled            (35,000)          3.88  -    12.50
                                    --------------------------------------------
September 30, 1996                      3,295,050          $3.88  -   $21.50
Granted                                   587,000           6.38  -     7.13
Exercised, expired or canceled             75,050           3.88  -    12.63
                                    --------------------------------------------
September 30, 1997                      3,807,000          $4.88  -   $21.50
                                    --------------------------------------------

        In February  1992,  the Company  issued  $40,000,000 in Azide Notes with
        Warrants.  See Note 6 for a description  of the  Warrants.  Shares under
        options  and  warrants  at  September  30,  1997  include  approximately
        2,857,000 Warrants at a price of $14 per Warrant.

        The  following  table  summarizes  information  about stock  options and
        warrants outstanding at September 30, 1997:
<TABLE>
<CAPTION>

                                        Options and Warrants Outstanding                                 Options Exercisable
                           -----------------------------------------------------------    -----------------------------------------
                                             Weighted Average                                                           Weighted
                                                Remaining                Weighted                                        Average
            Range of            Number         Contractual                Average                Number                  Exercise
         Exercise Price       Outstanding      Life (Years)            Exercise Price         Exercisable                 Price
        -----------------  --------------    --------------------   ----------------------   -----------------    ---------------
        <S>                  <C>                      <C>                <C>                    <C>                  <C>     
        $       4.88            40,000                2.5               $    4.88                  40,000            $   4.88
         5.63 - 7.50           860,000                4.1                    6.97                 569,000                7.07
               21.50            50,000                1.0                   21.50                  50,000               21.50
               14.00         2,857,000                6.0                   14.00               2,857,000               14.00
                             ---------       ---------------------   ----------------------   -----------------    ---------------
                             3,807,000                5.49               $  13.23               3,516,000            $  13.60
                             =========       =====================   ======================   =================    ===============
</TABLE>


                                       54
<PAGE>
12.     SEGMENT INFORMATION

        The  Company's  principal  business  segments are  specialty  chemicals,
        environmental     protection     equipment    and    technology,     and
        industrial/commercial and residential real estate development.  Products
        of the specialty  chemicals  segment include AP used in the solid rocket
        propellant for the space shuttle and defense programs, other perchlorate
        chemicals, sodium azide, and Halotron.

        Information about the Company's industry segments is as follows:
<TABLE>
<CAPTION>

                                             ---------------------------------------------
                                                        Years ended September 30,
                                             ---------------------------------------------
                                                 1997            1996            1995
                                                 ----            ----            ----
Revenues:
<S>                                          <C>             <C>             <C>         
Specialty chemicals                          $ 37,976,000    $ 34,061,000    $ 34,219,000
Environmental protection                        2,429,000       3,099,000       1,656,000
Real estate                                     3,645,000       5,221,000       3,375,000
                                             ------------    ------------    ------------

Total                                        $ 44,050,000    $ 42,381,000    $ 39,250,000
                                             ============    ============    ============

Operating income (loss) before
    unallocated income and expenses:
Specialty chemicals                          $(55,227,000)   $   (879,000)   $ (2,150,000)
Environmental protection                         (659,000)       (249,000)       (640,000)
Real estate                                     1,624,000       2,069,000       1,356,000
                                             ------------    ------------    ------------

Total                                         (54,262,000)        941,000      (1,434,000)
                                             ------------    ------------    ------------

Deduct (add) unallocated expense (income):
General corporate(1)                            3,838,000         506,000         613,000
Equity in earnings of real estate venture        (200,000)       (700,000)
Interest and other income                      (1,115,000)     (1,381,000)     (1,429,000)
Interest and other expense                      2,001,000       2,836,000       1,709,000
Income tax credit                             (10,101,000)       (109,000)       (791,000)
                                             ------------    ------------    ------------

Net loss                                     $(48,685,000)   $   (211,000)   $ (1,538,000)
                                             ============    ============    ============

Specialty chemicals                          $ 32,166,000    $ 91,869,000    $ 95,845,000
Environmental protection                        1,667,000       1,476,000       1,087,000
Real estate                                    29,215,000      28,996,000      29,827,000
Corporate                                      27,033,000      27,678,000      28,460,000
                                             ------------    ------------    ------------

Total                                        $ 90,081,000    $150,019,000    $155,219,000
                                             ------------    ------------    ------------
Financial information relating to domestic
   and export sales (domestic operations):
Domestic revenues                            $ 42,723,000    $ 40,029,000    $ 38,857,000
Export revenues                                 1,327,000       2,784,000         393,000
                                             ------------    ------------    ------------

Total                                        $ 44,050,000    $ 42,381,000    $ 39,250,000
                                             ============    ============    ============
</TABLE>

(1)     The  increase in general  corporate  expenses in fiscal 1997  relates to
        employee  separation and management  reorganization  costs recognized in
        the fourth quarter. (See Note 16.)


                                       55
<PAGE>
        The Company's  operations  are located in the United  States.  It is not
        practicable  to  compute a measure of  profitability  for  domestic  and
        export  sales or for sales by  geographic  location.  Substantially  all
        export revenues relate to  environmental  protection  equipment sales in
        the Far and Middle East.









                                      55-A
<PAGE>

        The  majority  of  depreciation  and  amortization  expense  and capital
        expenditures  relate  to  the  Company's  specialty  chemicals  segment.
        Depreciation and amortization  expenses for the years ended September 30
        are as follows:

                          ----------------------------------------------
                                1997            1996           1995
                          ----------------------------------------------
Specialty chemicals        $ 6,749,000      $6,899,000       $4,824,000
All other segments             936,000         911,000        1,059,000
                          ----------------------------------------------


Total                      $ 7,685,000      $7,810,000       $5,883,000
                          ==============================================

        Capital expenditures for the years ended September 30 are as follows:

                          ---------------------------------------------
                                  1997                   1996
                          ---------------------------------------------
Specialty chemicals       $     1,524,000        $     3,157,000
All other segments                 33,000                 91,000
                          ----------------------------------------------
Total                     $     1,557,000        $     3,248,000
                          =============================================

        The Company had three  customers  that  accounted for 10% or more of the
        Company's  revenues in one or more of fiscal 1997, 1996 and 1995.  These
        three customers accounted respectively for the following revenues during
        the fiscal years ended September 30:
<TABLE>
<CAPTION>

                                                            -----------------------------------------------------
  Customer              Chemical               Industry              1997        1996                1995
-----------------------------------------------------------------------------------------------------------------
<S>            <C>                          <C>              <C>               <C>                 <C>
      A        Ammonium Perchlorate         Space            $15,661,000       $20,000,000         $27,963,000
      B        Ammonium Perchlorate         Space              4,614,000
      C        Sodium Azide                 Airbag            11,715,000         9,378,000
                                                            -----------------------------------------------------
</TABLE>

13.     SODIUM AZIDE

        In  July  1990,  the  Company   entered  into   agreements  (the  "Azide
        Agreements")  pursuant to which Dynamit Nobel licensed to the Company on
        an  exclusive  basis for the North  American  market  its most  advanced
        technology  and  know-how  for  the  production  of  sodium  azide,  the
        principal component of the gas generant used in automotive airbag safety
        systems.  In addition,  Dynamit Nobel has provided technical support for
        the design, construction and start-up of the facility.

        Under the Azide Agreements, Dynamit Nobel was to receive, for the use of
        its technology and know-how relating to its batch production  process of
        manufacturing  sodium  azide,  quarterly  royalty  payments of 5% of the
        quarterly net sales of sodium azide by AAC for a period of 15 years from
        the date the  Company  begins  to  produce  sodium  azide in  commercial
        quantities.  In July 1996,  the  Company  and  Dynamit  Nobel  agreed to
        suspend the royalty  payment  effective as of July 1, 1995. As a result,
        in the third quarter of fiscal 1996, the Company  recognized an increase
        in  sodium  azide  sales of  approximately  $600,000.  This  amount  had
        previously  been  recognized  as a reduction  of net sodium  azide sales
        during the period July 1, 1995 through June 30, 1996.

        In May 1997,  the  Company  entered  into a  three-year  agreement  with
        Autoliv ASP, Inc. ("Autoliv") (formerly Morton International  Automotive
        Safety  Products).  The  agreement  provides  for the  Company to supply
        sodium azide used by Autoliv in the  manufacture of automotive  airbags.
        Deliveries  under the  contract  commenced in July 1997.  The  estimated
        sales value of the agreement is approximately $45 - $55 million over the
        three-

                                       56
<PAGE>
        year period.  This actual sales  value,  however,  will depend upon many
        factors  beyond  the  control  of the  Company,  such as the  number  of
        automobiles and light trucks manufactured and competitive  conditions in
        the airbag market, that will influence the actual magnitude of Autoliv's
        sodium azide requirements, and there can therefore be no assurance as to
        the actual sales value of the agreement.

       The Company  previously  believed  that demand for sodium  azide in North
       America and the world would substantially  exceed existing  manufacturing
       capacity  and  announced  expansions  or new  facilities  (including  the
       Company's  plant) by the 1994 model year  (which for sodium  azide  sales
       purposes is the period June 1993 through May 1994). Currently, demand for
       sodium azide is substantially  less than supply on a worldwide basis. The
       Company  believes  this is the result of capacity  expansions by existing
       producers,   although   the   Company's   information   with  respect  to
       competitors'  existing and planned  capacity is limited.  There can be no
       assurance  that  other  manufacturing  capacities  not now  known  to the
       Company  will not be  established.  By reason of this highly  competitive
       market  environment,  and other  factors  discussed  below,  there exists
       considerable pressure on the price of sodium azide.

        The Company  believes  that the price  erosion of sodium  azide over the
        past few years has been due, in part, to unlawful pricing  procedures of
        Japanese  sodium  azide  producers.  In response to such  practices,  in
        January  1996,  the  Company  filed  an  antidumping  petition  with the
        International  Trade  Commission  ("ITC") and the Department of Commerce
        ("Commerce").   In   August   1996,   Commerce   issued  a   preliminary
        determination  that  Japanese  imports of sodium azide have been sold in
        the United  States at prices  that are  significantly  below fair value.
        Commerce's  preliminary  dumping  determination  applied to all Japanese
        imports of sodium azide,  regardless of end-use.  Commerce's preliminary
        determination  followed a March 1996  preliminary  determination  by ITC
        that dumped  Japanese  imports have caused  material  injury to the U.S.
        sodium azide industry.

        On January 7, 1997 the anti-dumping investigation initiated by Commerce,
        based upon the Company's petition,  against the three Japanese producers
        of  sodium  azide  was  suspended  by  agreement.  It is  the  Company's
        understanding  that, by reason of the Suspension  Agreement,  two of the
        three  Japanese  sodium azide  producers  have ceased  their  exports of
        sodium  azide to the United  States for the time being.  As to the third
        and largest  Japanese sodium azide producer,  which has not admitted any
        prior unlawful conduct,  the Suspension  Agreement requires that it make
        all  necessary  price  revisions to eliminate all United States sales at
        below  "Normal  Value,"  and  that it  conform  to the  requirements  of
        sections  732  and  733 of  the  Tariff  Act of  1930,  as  amended,  in
        connection with its future sales of sodium azide in the United States.

        The  Suspension  Agreement  contemplates a cost-based  determination  of
        "Normal Value" and establishes reporting and verification  procedures to
        assure  compliance.  Accordingly,  the minimum  pricing for sodium azide
        sold in the United  States by the  remaining  Japanese  producer will be
        based  primarily on its actual costs,  and may be affected by changes in
        the relevant exchange rates.

        Finally,  the Suspension Agreement provides that it may be terminated by
        any party on 60 days' notice, in which event the anti-dumping proceeding
        would be re-instituted at the stage to which it had advanced at the time
        the Suspension Agreement became effective.


                                       57
<PAGE>
        The  Company has  incurred  significant  operating  losses in its sodium
        azide  operation  during  the last  three  fiscal  years.  Sodium  azide
        performance  improved in the fourth quarter of fiscal 1997,  principally
        as a result of  additional  sodium  azide  deliveries  under the Autoliv
        agreement  referred to above, and the operations were cash flow positive
        during  the  year  ended  September  30,  1997.  However,   even  though
        performance  improved,  Management's view of the economics of the sodium
        azide market changed during the fourth quarter of fiscal 1997. One major
        inflator  manufacturer  announced  the  acquisition  of non-azide  based
        inflator technology and that they intended to be in the market with this
        new technology by model year 1999. In addition, although the Company has
        achieved  significant gains in market share that appear to relate to the
        Company's   anti-  dumping   petition  and  the  Suspension   Agreement,
        Management  believes that the effects of the anti-dumping  petition were
        likely  fully  incorporated  into the sodium  azide market by the end of
        fiscal 1997.  Recognizing that the  uncertainties  respecting the market
        and  discussed  above  continue to exist,  during the fourth  quarter of
        fiscal 1997,  Management  concluded that the cash flows  associated with
        sodium azide operations would not be sufficient to recover the Company's
        investment in sodium azide related fixed assets. As quoted market prices
        were not available, the present value of estimated future cash flows was
        used to estimate the fair value of sodium azide fixed assets.  Under the
        requirements  of  SFAS  No.  121,  and as a  result  of  this  valuation
        technique,  an impairment  charge of  $52,605,000  was recognized in the
        fourth quarter of fiscal 1997.

14.     HALOTRON

        On August 30, 1991, the Company entered into an agreement (the "Halotron
        Agreement")  granting  the Company  the option to acquire the  exclusive
        worldwide  rights to manufacture  and sell Halotron I (a replacement for
        halon 1211). Halotron products are fire suppression systems, including a
        series of chemical compounds and application  technologies,  designed to
        replace halons,  chemicals  presently in wide use as a fire  suppression
        agent in military, industrial, commercial and residential applications.

        The Halotron  Agreement  provides for  disclosure  to the Company of all
        confidential and proprietary  information  concerning  Halotron I, which
        together   with  testing   undergone   by  Halotron  I  at   independent
        laboratories  in Sweden and the United  States and  consulting  services
        that were  provided,  was  intended  to enable the  Company to  evaluate
        Halotron I's commercial  utility and feasibility.  In February 1992, the
        Company announced that a series of technical evaluations and field tests
        conducted  at the  University  of  New  Mexico  had  been  positive  and
        equivalent  to the  performance  previously  reported  in testing at the
        Swedish  National  Institute of Testing and Standards and the University
        of Lund in Sweden.

        In February 1992, the Company  determined to acquire the rights provided
        for in the  Halotron  Agreement,  gave  notice  to  that  effect  to the
        inventors,  and  exercised  its option.  In  addition  to the  exclusive
        license to manufacture  and sell Halotron I, the rights  acquired by the
        Company include rights under all present and future patents  relating to
        Halotron  I  throughout  the  world,  rights to  related  and  follow-on
        products  and  technologies  and  product and  technology  improvements,
        rights to reclaim,  store and distribute halon and rights to utilize the
        productive  capacity of the inventors' Swedish  manufacturing  facility.
        Upon  exercise of the option,  the Company paid the sum of $700,000 (the
        exercise price of $1,000,000, less advance payments previously made) and
        became  obligated to pay the further sum of  $1,500,000 in equal monthly
        installments of $82,000, commencing in

                                       58
<PAGE>
        March 1992. The license  agreement  entered into between the Company and
        the  inventors of Halotron I provides for a royalty to the  inventors of
        5% of the Company's net sales of Halotron I over a period of 15 years.

        The Company has designed and constructed a Halotron facility that has an
        annual capacity of approximately 6,000,000 pounds, located on land owned
        by the Company in Iron County, Utah.

        As discussed above, in 1992, the Company purchased the rights to certain
        fire  suppression  chemicals and delivery  systems called  Halotron from
        their Swedish  inventor,  Jan Andersson and his  corporation,  AB Bejaro
        Product.  The Company  claimed that  Andersson  and Bejaro  breached the
        contract  in which they had sold the rights to  Halotron.  This  alleged
        breach  resulted in  litigation  initiated by the Company.  This initial
        litigation  was settled when  Andersson  and Bejaro  promised to perform
        faithfully  their duties and to honor the terms of the  contracts  that,
        among other things,  gave the Company  exclusive  rights to the Halotron
        chemicals and delivery systems.

        Following the settlement of the initial litigation,  however,  Andersson
        and Bejaro  failed to  perform  the acts they had  promised  in order to
        secure  dismissal  of  that  litigation.  As a  result,  litigation  was
        initiated  in the Utah state  courts in March  1994,  for the purpose of
        establishing the Company's  exclusive  rights to the Halotron  chemicals
        and delivery  systems.  On August 15, 1994,  the court entered a default
        judgment   ("Judgment")   against  Andersson  and  Bejaro  granting  the
        injunctive  relief  requested by the Company and awarding damages in the
        amount of $42,233,000.

        The  trial  court  further  ordered  Andersson  and  Bejaro  to  execute
        documents  required  for  patent  registration  of  Halotron  in various
        countries.  When  Andersson  and Bejaro  ignored  this order,  the Court
        directed the Clerk of the Court to execute these  documents on behalf of
        Andersson and Bejaro.  Finally,  the Court ordered that  Andersson's and
        Bejaro's  rights to any future  royalties  from sales of  Halotron  were
        terminated.  The Company is exploring  ways to collect the Judgment from
        Andersson  and Bejaro.  It appears  that  Andersson  and Bejaro have few
        assets and those  assets they do have appear to have been placed  beyond
        reach of the Judgment.

        The Company has initiated arbitration  proceedings against Jan Andersson
        and Bejaro to  enforce  Halotron's  patent  rights to  Halotron  against
        Andersson.  The parties have each submitted  statements of claims,  with
        supporting  documents,  affidavits and briefs to the arbitration  panel.
        Jan Andersson and Bejaro have also asserted a  counterclaim  against the
        Company,  alleging that the Company  wrongfully  deprived  Andersson and
        Bejaro of royalties due under the agreements with the Company. Andersson
        and Bejaro seek  $6,200,000,  including  damages  for  alleged  physical
        suffering  and  punitive  damages.  The Company has sought to strike the
        counterclaim as having been filed untimely.  If the  counterclaim is not
        stricken,  the Company will  vigorously  contest claims  asserted in the
        counterclaim. The Company believes the counterclaim to be without merit.
        No hearing has been set in the arbitration.

15.     ASSET PURCHASE AGREEMENT

        On  October  10,  1997,  the  Company  entered  into an  Asset  Purchase
        Agreement (the "Agreement") with Kerr-McGee.  The Agreement contemplates
        that  the  Company  will  acquire   certain   process  data,   technical
        information, customer lists, marketing contacts,

                                       59
<PAGE>
        and related  expertise used by Kerr-McGee  primarily in the AP industry.
        The Agreement calls for a purchase price of $39 million,  and grants the
        Company the option to purchase  limited AP inventory of  Kerr-McGee  for
        additional consideration.

        Closing  of the  transaction  is  subject  to a  number  of  conditions,
        including  the  Company's  securing of financing  for 100 percent of the
        purchase  price and Board of  Director  approvals  by both  parties.  In
        December 1997, the Company received  notification that the Federal Trade
        Commission  ("FTC") had  determined  to grant early  termination  of the
        waiting  period  relating to the  Company's and  Kerr-McGee's  premerger
        notifications  filings with the FTC and the  Department of Justice under
        the Hart-Scott-  Rodino Antitrust  Improvements Act of 1976. The Company
        has entered  into  long-term  pricing  agreements  for AP with its major
        customers that are contingent upon the closing of the  transaction  and,
        on a continuing  basis,  that will be contingent  upon  agreement on the
        terms of specific purchase orders.

        There  can  be no  assurance  that  the  conditions  to  closing  of the
        transaction  will be satisfied,  or that the transaction will close. The
        management of the Company will, however,  make all reasonable efforts to
        meet all conditions, and to conclude successfully this transaction.

16.     EMPLOYEE SEPARATION AND MANAGEMENT REORGANIZATION COSTS

        During the fourth  quarter of fiscal  1997,  the Company  implemented  a
        management  reorganization plan. As a result, the former Chief Executive
        Officer,  Executive  Vice  President  and two  other  senior  executives
        separated  their  employment  with the Company  and the Company  vacated
        approximately  one-half of its leased corporate office facilities space.
        In addition,  activities  associated  with the  Company's  environmental
        protection  equipment  division  were  relocated to the  Company's  Utah
        facilities.

        The Company  recognized a charge of  $3,616,000 to account for the costs
        associated with the employee  separations and vacating leased space. The
        charge consists principally of four years of salary and benefits payable
        to the former  Executive Vice President under the terms of an employment
        agreement,  the present  value of the  estimated  amount  payable to the
        former  Chief  Executive  Officer  under  the  terms  of  the  Company's
        Supplemental  Executive  Retirement  Plan ("SERP") and  severance  costs
        payable to the two other  former  senior  executives.  The former  Chief
        Executive Officer is the only person currently covered under the SERP.

        Relocation costs amounted to  approximately  $387,000 and are classified
        in  operating  expenses in the  accompanying  consolidated  statement of
        operations.

        In the third  quarter  of 1995,  the  Company  reduced  total  full-time
        employee  equivalents by approximately  ten percent through  involuntary
        terminations  and an  offering  of  enhanced  retirement  benefits  to a
        certain  class  of  employees.   The  Company  recognized  a  charge  of
        approximately  $226,000  as a  result  of  these  terminations  and  the
        acceptance  of the offer of  enhanced  retirement  benefits  by  certain
        employees.




                                       60